Frequencies for first 10,000 rows of pt variable in reac2007q3 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 12 0.12 0.12 ABDOMINAL ABSCESS | 1 0.01 0.13 ABDOMINAL DISCOMFORT | 4 0.04 0.17 ABDOMINAL DISTENSION | 25 0.25 0.42 ABDOMINAL MASS | 1 0.01 0.43 ABDOMINAL OPERATION | 1 0.01 0.44 ABDOMINAL PAIN | 44 0.44 0.88 ABDOMINAL PAIN LOWER | 7 0.07 0.95 ABDOMINAL PAIN UPPER | 32 0.32 1.27 ABDOMINAL RIGIDITY | 1 0.01 1.28 ABNORMAL BEHAVIOUR | 18 0.18 1.46 ABNORMAL DREAMS | 6 0.06 1.52 ABNORMAL SENSATION IN EYE | 2 0.02 1.54 ABORTION INDUCED | 2 0.02 1.56 ABORTION SPONTANEOUS | 16 0.16 1.72 ABSCESS | 4 0.04 1.76 ABSCESS DRAINAGE | 1 0.01 1.77 ABSCESS JAW | 2 0.02 1.79 ABSCESS LIMB | 2 0.02 1.81 ABSCESS ORAL | 1 0.01 1.82 ACCIDENT | 1 0.01 1.83 ACCIDENTAL DRUG INTAKE BY CHILD | 2 0.02 1.85 ACCIDENTAL EXPOSURE | 3 0.03 1.88 ACCIDENTAL OVERDOSE | 5 0.05 1.93 ACETONAEMIA | 2 0.02 1.95 ACHOLIA | 1 0.01 1.96 ACIDOSIS | 3 0.03 1.99 ACINETOBACTER INFECTION | 1 0.01 2.00 ACNE | 2 0.02 2.02 ACOUSTIC STIMULATION TESTS ABNORMAL | 1 0.01 2.03 ACQUIRED OESOPHAGEAL WEB | 1 0.01 2.04 ACRODERMATITIS | 1 0.01 2.05 ACTINIC KERATOSIS | 2 0.02 2.07 ACTINOMYCOSIS | 2 0.02 2.09 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 3 0.03 2.12 ACTIVATION SYNDROME | 1 0.01 2.13 ACTIVITIES OF DAILY LIVING IMPAIRED | 5 0.05 2.18 ACUTE ABDOMEN | 1 0.01 2.19 ACUTE CORONARY SYNDROME | 5 0.05 2.24 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 4 0.04 2.28 ACUTE GRAFT VERSUS HOST DISEASE IN IN.. | 1 0.01 2.29 ACUTE GRAFT VERSUS HOST DISEASE IN LI.. | 1 0.01 2.30 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 2 0.02 2.32 ACUTE HEPATIC FAILURE | 1 0.01 2.33 ACUTE MYELOID LEUKAEMIA | 9 0.09 2.42 ACUTE MYOCARDIAL INFARCTION | 6 0.06 2.48 ACUTE PHASE REACTION | 1 0.01 2.49 ACUTE PRERENAL FAILURE | 1 0.01 2.50 ACUTE PULMONARY OEDEMA | 4 0.04 2.54 ACUTE RESPIRATORY DISTRESS SYNDROME | 8 0.08 2.62 ACUTE RESPIRATORY FAILURE | 6 0.06 2.68 ACUTE SINUSITIS | 1 0.01 2.69 ADDISON'S DISEASE | 1 0.01 2.70 ADENOMA BENIGN | 1 0.01 2.71 ADENOVIRUS INFECTION | 2 0.02 2.73 ADHESION | 1 0.01 2.74 ADRENAL ADENOMA | 1 0.01 2.75 ADRENAL DISORDER | 1 0.01 2.76 ADRENAL INSUFFICIENCY | 3 0.03 2.79 ADVERSE DRUG REACTION | 7 0.07 2.86 ADVERSE EVENT | 4 0.04 2.90 AFFECT LABILITY | 2 0.02 2.92 AFFECTIVE DISORDER | 1 0.01 2.93 AGEUSIA | 6 0.06 2.99 AGGRESSION | 14 0.14 3.13 AGITATION | 21 0.21 3.34 AGITATION NEONATAL | 1 0.01 3.35 AGRANULOCYTOSIS | 7 0.07 3.42 AKATHISIA | 3 0.03 3.45 ALANINE AMINOTRANSFERASE | 1 0.01 3.46 ALANINE AMINOTRANSFERASE INCREASED | 36 0.36 3.82 ALCOHOL POISONING | 1 0.01 3.83 ALCOHOL USE | 2 0.02 3.85 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 3.86 ALCOHOLIC PANCREATITIS | 1 0.01 3.87 ALCOHOLISM | 2 0.02 3.89 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.90 ALLERGIC RESPIRATORY SYMPTOM | 1 0.01 3.91 ALLERGY TEST POSITIVE | 1 0.01 3.92 ALLERGY TO CHEMICALS | 1 0.01 3.93 ALOPECIA | 17 0.17 4.10 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 4.11 ALTERED STATE OF CONSCIOUSNESS | 7 0.07 4.18 AMENORRHOEA | 3 0.03 4.21 AMNESIA | 15 0.15 4.36 AMNIOTIC FLUID INDEX ABNORMAL | 1 0.01 4.37 AMPUTATION REVISION | 1 0.01 4.38 ANAEMIA | 59 0.59 4.97 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 2 0.02 4.99 ANAEMIA MACROCYTIC | 1 0.01 5.00 ANAL FISSURE | 2 0.02 5.02 ANAPHYLACTIC REACTION | 8 0.08 5.10 ANAPHYLACTIC SHOCK | 9 0.09 5.19 ANAPHYLACTOID REACTION | 2 0.02 5.21 ANAPHYLACTOID SHOCK | 2 0.02 5.23 ANASTOMOTIC LEAK | 1 0.01 5.24 ANEURYSM | 1 0.01 5.25 ANGINA PECTORIS | 13 0.13 5.38 ANGINA UNSTABLE | 1 0.01 5.39 ANGIOEDEMA | 7 0.07 5.46 ANGIOPATHY | 2 0.02 5.48 ANGIOPLASTY | 1 0.01 5.49 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.50 ANHEDONIA | 2 0.02 5.52 ANKLE FRACTURE | 1 0.01 5.53 ANKYLOGLOSSIA CONGENITAL | 1 0.01 5.54 ANKYLOSING SPONDYLITIS | 1 0.01 5.55 ANOREXIA | 40 0.40 5.95 ANOSMIA | 4 0.04 5.99 ANOTIA | 1 0.01 6.00 ANOXIC ENCEPHALOPATHY | 1 0.01 6.01 ANTIBIOTIC PROPHYLAXIS | 1 0.01 6.02 ANTIBODY TEST | 1 0.01 6.03 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 6.04 ANTICONVULSANT DRUG LEVEL BELOW THERA.. | 2 0.02 6.06 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 6.07 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY I.. | 1 0.01 6.08 ANTINUCLEAR ANTIBODY POSITIVE | 2 0.02 6.10 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 1 0.01 6.11 ANURIA | 5 0.05 6.16 ANXIETY | 44 0.44 6.60 AORTIC ANEURYSM | 2 0.02 6.62 AORTIC DISORDER | 1 0.01 6.63 AORTIC SURGERY | 1 0.01 6.64 AORTIC VALVE INCOMPETENCE | 2 0.02 6.66 APGAR SCORE LOW | 1 0.01 6.67 APHASIA | 7 0.07 6.74 APHONIA | 2 0.02 6.76 APHTHOUS STOMATITIS | 4 0.04 6.80 APLASIA | 1 0.01 6.81 APLASIA PURE RED CELL | 5 0.05 6.86 APLASTIC ANAEMIA | 3 0.03 6.89 APNOEA | 5 0.05 6.94 APPENDICECTOMY | 1 0.01 6.95 APPENDICITIS | 2 0.02 6.97 APPETITE DISORDER | 1 0.01 6.98 APPLICATION SITE EXCORIATION | 1 0.01 6.99 APPLICATION SITE PARAESTHESIA | 1 0.01 7.00 APPLICATION SITE PRURITUS | 1 0.01 7.01 APPLICATION SITE RASH | 1 0.01 7.02 APPLICATION SITE URTICARIA | 1 0.01 7.03 APRAXIA | 1 0.01 7.04 APTYALISM | 1 0.01 7.05 AREFLEXIA | 1 0.01 7.06 ARRHYTHMIA | 17 0.17 7.23 ARTERIAL BYPASS OPERATION | 1 0.01 7.24 ARTERIAL DISORDER | 1 0.01 7.25 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 7.27 ARTERIAL STENOSIS | 1 0.01 7.28 ARTERIAL THROMBOSIS LIMB | 1 0.01 7.29 ARTERIOGRAM CORONARY ABNORMAL | 1 0.01 7.30 ARTERIOSCLEROSIS | 3 0.03 7.33 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 7.34 ARTERIOSPASM CORONARY | 1 0.01 7.35 ARTERY DISSECTION | 1 0.01 7.36 ARTHRALGIA | 42 0.42 7.78 ARTHRITIS | 9 0.09 7.87 ARTHRITIS BACTERIAL | 5 0.05 7.92 ARTHRITIS REACTIVE | 1 0.01 7.93 ARTHROPATHY | 9 0.09 8.02 ARTHROPOD BITE | 1 0.01 8.03 ARTIFICIAL CROWN PROCEDURE | 1 0.01 8.04 ASCITES | 8 0.08 8.12 ASPARTATE AMINOTRANSFERASE INCREASED | 31 0.31 8.43 ASPHYXIA | 1 0.01 8.44 ASPIRATION | 9 0.09 8.53 ASPIRATION BONE MARROW | 1 0.01 8.54 ASPIRATION PLEURAL CAVITY | 1 0.01 8.55 ASTERIXIS | 1 0.01 8.56 ASTHENIA | 70 0.70 9.26 ASTHMA | 19 0.19 9.45 ASTHMATIC CRISIS | 2 0.02 9.47 ATELECTASIS | 2 0.02 9.49 ATRIAL FIBRILLATION | 18 0.18 9.67 ATRIAL FLUTTER | 3 0.03 9.70 ATRIAL NATRIURETIC PEPTIDE INCREASED | 1 0.01 9.71 ATRIAL SEPTAL DEFECT | 4 0.04 9.75 ATRIOVENTRICULAR BLOCK | 5 0.05 9.80 ATRIOVENTRICULAR BLOCK COMPLETE | 3 0.03 9.83 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 9.84 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 2 0.02 9.86 ATROPHY | 4 0.04 9.90 AURA | 1 0.01 9.91 AUTOANTIBODY TEST | 1 0.01 9.92 AUTOIMMUNE DISORDER | 2 0.02 9.94 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 9.95 AZOOSPERMIA | 1 0.01 9.96 AZOTAEMIA | 1 0.01 9.97 B-CELL LYMPHOMA | 1 0.01 9.98 BACK DISORDER | 3 0.03 10.01 BACK INJURY | 3 0.03 10.04 BACK PAIN | 45 0.45 10.49 BACTERAEMIA | 2 0.02 10.51 BACTERIA SPUTUM IDENTIFIED | 1 0.01 10.52 BACTERIAL INFECTION | 7 0.07 10.59 BACTERIAL SEPSIS | 3 0.03 10.62 BACTEROIDES INFECTION | 1 0.01 10.63 BALANCE DISORDER | 12 0.12 10.75 BASAL CELL CARCINOMA | 2 0.02 10.77 BASEDOW'S DISEASE | 1 0.01 10.78 BASOPHIL COUNT DECREASED | 1 0.01 10.79 BEDRIDDEN | 2 0.02 10.81 BEHCET'S SYNDROME | 1 0.01 10.82 BENIGN BREAST NEOPLASM | 1 0.01 10.83 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 1 0.01 10.84 BILE DUCT OBSTRUCTION | 1 0.01 10.85 BILE DUCT STENT INSERTION | 1 0.01 10.86 BILIRUBIN CONJUGATED INCREASED | 2 0.02 10.88 BIOPSY | 3 0.03 10.91 BIOPSY BONE MARROW ABNORMAL | 1 0.01 10.92 BIOPSY KIDNEY ABNORMAL | 1 0.01 10.93 BIOPSY SITE UNSPECIFIED ABNORMAL | 1 0.01 10.94 BIOPSY SKIN ABNORMAL | 1 0.01 10.95 BIPOLAR DISORDER | 3 0.03 10.98 BIPOLAR I DISORDER | 1 0.01 10.99 BLADDER CANCER | 3 0.03 11.02 BLADDER CATHETERISATION | 2 0.02 11.04 BLADDER DISORDER | 12 0.12 11.16 BLADDER MASS | 1 0.01 11.17 BLADDER PERFORATION | 1 0.01 11.18 BLADDER SPHINCTER ATONY | 1 0.01 11.19 BLAST CELLS PRESENT | 1 0.01 11.20 BLINDNESS | 9 0.09 11.29 BLINDNESS TRANSIENT | 2 0.02 11.31 BLINDNESS UNILATERAL | 4 0.04 11.35 BLISTER | 6 0.06 11.41 BLOOD ALBUMIN DECREASED | 6 0.06 11.47 BLOOD ALKALINE PHOSPHATASE INCREASED | 24 0.24 11.71 BLOOD AMINO ACID LEVEL INCREASED | 1 0.01 11.72 BLOOD AMYLASE INCREASED | 3 0.03 11.75 BLOOD BICARBONATE DECREASED | 1 0.01 11.76 BLOOD BILIRUBIN INCREASED | 8 0.08 11.84 BLOOD CALCIUM DECREASED | 3 0.03 11.87 BLOOD CHLORIDE DECREASED | 2 0.02 11.89 BLOOD CHLORIDE INCREASED | 1 0.01 11.90 BLOOD CHOLESTEROL ABNORMAL | 2 0.02 11.92 BLOOD CHOLESTEROL INCREASED | 10 0.10 12.02 BLOOD CORTISOL INCREASED | 1 0.01 12.03 BLOOD COUNT ABNORMAL | 6 0.06 12.09 BLOOD CREATINE INCREASED | 3 0.03 12.12 BLOOD CREATINE PHOSPHOKINASE INCREASED | 16 0.16 12.28 BLOOD CREATININE ABNORMAL | 1 0.01 12.29 BLOOD CREATININE INCREASED | 30 0.30 12.59 BLOOD CULTURE POSITIVE | 5 0.05 12.64 BLOOD ELECTROLYTES ABNORMAL | 1 0.01 12.65 BLOOD FOLATE DECREASED | 2 0.02 12.67 BLOOD GLUCOSE ABNORMAL | 1 0.01 12.68 BLOOD GLUCOSE DECREASED | 10 0.10 12.78 BLOOD GLUCOSE FLUCTUATION | 2 0.02 12.80 BLOOD GLUCOSE INCREASED | 39 0.39 13.19 BLOOD HIV RNA INCREASED | 1 0.01 13.20 BLOOD IMMUNOGLOBULIN A DECREASED | 1 0.01 13.21 BLOOD IMMUNOGLOBULIN A INCREASED | 1 0.01 13.22 BLOOD IMMUNOGLOBULIN G INCREASED | 2 0.02 13.24 BLOOD INSULIN DECREASED | 1 0.01 13.25 BLOOD IRON DECREASED | 1 0.01 13.26 BLOOD LACTATE DEHYDROGENASE INCREASED | 10 0.10 13.36 BLOOD LACTIC ACID INCREASED | 2 0.02 13.38 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 13.39 BLOOD POTASSIUM DECREASED | 11 0.11 13.50 BLOOD POTASSIUM INCREASED | 10 0.10 13.60 BLOOD PRESSURE ABNORMAL | 1 0.01 13.61 BLOOD PRESSURE DECREASED | 21 0.21 13.82 BLOOD PRESSURE DIASTOLIC DECREASED | 2 0.02 13.84 BLOOD PRESSURE FLUCTUATION | 7 0.07 13.91 BLOOD PRESSURE IMMEASURABLE | 1 0.01 13.92 BLOOD PRESSURE INADEQUATELY CONTROLLED | 7 0.07 13.99 BLOOD PRESSURE INCREASED | 30 0.30 14.29 BLOOD PRESSURE ORTHOSTATIC ABNORMAL | 1 0.01 14.30 BLOOD PRESSURE SYSTOLIC INCREASED | 1 0.01 14.31 BLOOD PROLACTIN INCREASED | 1 0.01 14.32 BLOOD SODIUM DECREASED | 9 0.09 14.41 BLOOD SODIUM INCREASED | 1 0.01 14.42 BLOOD TEST ABNORMAL | 2 0.02 14.44 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.45 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 14.46 BLOOD TRIGLYCERIDES INCREASED | 7 0.07 14.53 BLOOD UREA DECREASED | 2 0.02 14.55 BLOOD UREA INCREASED | 11 0.11 14.66 BLOOD URIC ACID INCREASED | 2 0.02 14.68 BLOOD URINE | 1 0.01 14.69 BODY HEIGHT DECREASED | 1 0.01 14.70 BODY TEMPERATURE DECREASED | 3 0.03 14.73 BODY TEMPERATURE INCREASED | 7 0.07 14.80 BONE DEBRIDEMENT | 2 0.02 14.82 BONE DENSITY DECREASED | 2 0.02 14.84 BONE DEVELOPMENT ABNORMAL | 1 0.01 14.85 BONE DISORDER | 8 0.08 14.93 BONE EROSION | 1 0.01 14.94 BONE GRAFT | 1 0.01 14.95 BONE LESION | 1 0.01 14.96 BONE MARROW FAILURE | 8 0.08 15.04 BONE MARROW ISCHAEMIA | 1 0.01 15.05 BONE MARROW NECROSIS | 1 0.01 15.06 BONE MARROW OEDEMA | 1 0.01 15.07 BONE MARROW TUMOUR CELL INFILTRATION | 1 0.01 15.08 BONE PAIN | 8 0.08 15.16 BONE SWELLING | 1 0.01 15.17 BONE TRIMMING | 1 0.01 15.18 BOWEN'S DISEASE | 1 0.01 15.19 BRADYCARDIA | 22 0.22 15.41 BRADYCARDIA NEONATAL | 1 0.01 15.42 BRADYPHRENIA | 2 0.02 15.44 BRAIN ABSCESS | 1 0.01 15.45 BRAIN DEATH | 1 0.01 15.46 BRAIN HERNIATION | 1 0.01 15.47 BRAIN HYPOXIA | 1 0.01 15.48 BRAIN NATRIURETIC PEPTIDE | 1 0.01 15.49 BRAIN NATRIURETIC PEPTIDE INCREASED | 3 0.03 15.52 BRAIN NEOPLASM | 1 0.01 15.53 BRAIN OEDEMA | 6 0.06 15.59 BRAIN STEM ISCHAEMIA | 1 0.01 15.60 BREAKTHROUGH PAIN | 1 0.01 15.61 BREAST CANCER | 12 0.12 15.73 BREAST CANCER FEMALE | 5 0.05 15.78 BREAST CANCER IN SITU | 1 0.01 15.79 BREAST CANCER METASTATIC | 7 0.07 15.86 BREAST CYST | 1 0.01 15.87 BREAST HYPERPLASIA | 1 0.01 15.88 BREAST MICROCALCIFICATION | 2 0.02 15.90 BREAST OPERATION | 1 0.01 15.91 BREAST PAIN | 3 0.03 15.94 BREAST SWELLING | 2 0.02 15.96 BRONCHIAL OBSTRUCTION | 2 0.02 15.98 BRONCHIECTASIS | 4 0.04 16.02 BRONCHIOLITIS | 3 0.03 16.05 BRONCHITIS | 8 0.08 16.13 BRONCHITIS CHRONIC | 1 0.01 16.14 BRONCHOPLEURAL FISTULA | 1 0.01 16.15 BRONCHOPNEUMONIA | 4 0.04 16.19 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 16.21 BRONCHOSPASM | 6 0.06 16.27 BUNDLE BRANCH BLOCK | 1 0.01 16.28 BUNDLE BRANCH BLOCK LEFT | 4 0.04 16.32 BUNDLE BRANCH BLOCK RIGHT | 1 0.01 16.33 BURNING SENSATION | 8 0.08 16.41 BURNS SECOND DEGREE | 1 0.01 16.42 BURSITIS | 1 0.01 16.43 C-REACTIVE PROTEIN INCREASED | 12 0.12 16.55 CACHEXIA | 1 0.01 16.56 CAECITIS | 1 0.01 16.57 CAESAREAN SECTION | 8 0.08 16.65 CALCINOSIS | 1 0.01 16.66 CALCIPHYLAXIS | 1 0.01 16.67 CALCULUS URETERIC | 1 0.01 16.68 CANDIDA SEROLOGY POSITIVE | 1 0.01 16.69 CANDIDIASIS | 1 0.01 16.70 CAPILLARY PERMEABILITY INCREASED | 3 0.03 16.73 CARCINOEMBRYONIC ANTIGEN INCREASED | 1 0.01 16.74 CARDIAC ABLATION | 1 0.01 16.75 CARDIAC ARREST | 33 0.33 17.08 CARDIAC DISORDER | 9 0.09 17.17 CARDIAC ENZYMES INCREASED | 3 0.03 17.20 CARDIAC FAILURE | 15 0.15 17.35 CARDIAC FAILURE CONGESTIVE | 12 0.12 17.47 CARDIAC FLUTTER | 4 0.04 17.51 CARDIAC INFECTION | 1 0.01 17.52 CARDIAC MURMUR | 1 0.01 17.53 CARDIAC PACEMAKER INSERTION | 2 0.02 17.55 CARDIAC PACEMAKER MALFUNCTION | 1 0.01 17.56 CARDIAC STRESS TEST | 1 0.01 17.57 CARDIAC STRESS TEST ABNORMAL | 3 0.03 17.60 CARDIAC TAMPONADE | 2 0.02 17.62 CARDIAC VALVE DISEASE | 3 0.03 17.65 CARDIAC VENTRICULAR DISORDER | 1 0.01 17.66 CARDIO-RESPIRATORY ARREST | 3 0.03 17.69 CARDIOGENIC SHOCK | 1 0.01 17.70 CARDIOMEGALY | 7 0.07 17.77 CARDIOMYOPATHY | 3 0.03 17.80 CARDIOPULMONARY FAILURE | 1 0.01 17.81 CARDIOTOXICITY | 1 0.01 17.82 CARDIOVASCULAR DISORDER | 2 0.02 17.84 CARDIOVASCULAR INSUFFICIENCY | 2 0.02 17.86 CARDIOVERSION | 1 0.01 17.87 CAROTID ARTERIOSCLEROSIS | 1 0.01 17.88 CAROTID ARTERY DISEASE | 1 0.01 17.89 CAROTID ARTERY STENT INSERTION | 1 0.01 17.90 CAROTID ENDARTERECTOMY | 1 0.01 17.91 CARPAL TUNNEL SYNDROME | 4 0.04 17.95 CARTILAGE INJURY | 1 0.01 17.96 CATARACT | 9 0.09 18.05 CATARACT OPERATION | 3 0.03 18.08 CATATONIA | 5 0.05 18.13 CATHETER PLACEMENT | 1 0.01 18.14 CATHETER RELATED COMPLICATION | 1 0.01 18.15 CATHETER SEPSIS | 2 0.02 18.17 CATHETER SITE ERYTHEMA | 1 0.01 18.18 CATHETER SITE HAEMATOMA | 1 0.01 18.19 CATHETER SITE INFECTION | 1 0.01 18.20 CATHETER SITE PAIN | 1 0.01 18.21 CATHETERISATION CARDIAC | 4 0.04 18.25 CD4 LYMPHOCYTES DECREASED | 1 0.01 18.26 CELLULITIS | 7 0.07 18.33 CELLULITIS ORBITAL | 2 0.02 18.35 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 18.36 CEREBELLAR HYPOPLASIA | 1 0.01 18.37 CEREBRAL DISORDER | 2 0.02 18.39 CEREBRAL HAEMANGIOMA | 1 0.01 18.40 CEREBRAL HAEMATOMA | 1 0.01 18.41 CEREBRAL HAEMORRHAGE | 12 0.12 18.53 CEREBRAL INFARCTION | 12 0.12 18.65 CEREBRAL THROMBOSIS | 1 0.01 18.66 CEREBROVASCULAR ACCIDENT | 31 0.31 18.97 CEREBROVASCULAR SPASM | 1 0.01 18.98 CERVICAL DYSPLASIA | 1 0.01 18.99 CERVICAL ROOT PAIN | 1 0.01 19.00 CHANGE OF BOWEL HABIT | 1 0.01 19.01 CHAPPED LIPS | 1 0.01 19.02 CHEILITIS | 1 0.01 19.03 CHEMOTHERAPY | 1 0.01 19.04 CHEST DISCOMFORT | 13 0.13 19.17 CHEST PAIN | 58 0.58 19.75 CHEST X-RAY ABNORMAL | 3 0.03 19.78 CHILLS | 23 0.23 20.01 CHOANAL ATRESIA | 1 0.01 20.02 CHOKING | 3 0.03 20.05 CHOKING SENSATION | 1 0.01 20.06 CHOLANGITIS | 3 0.03 20.09 CHOLECYSTECTOMY | 4 0.04 20.13 CHOLECYSTITIS | 1 0.01 20.14 CHOLECYSTITIS ACUTE | 1 0.01 20.15 CHOLELITHIASIS | 5 0.05 20.20 CHOLESTASIS | 3 0.03 20.23 CHOLURIA | 1 0.01 20.24 CHONDROMALACIA | 1 0.01 20.25 CHORIORETINOPATHY | 1 0.01 20.26 CHROMATURIA | 4 0.04 20.30 CHROMOSOME ANALYSIS ABNORMAL | 1 0.01 20.31 CHRONIC HEPATITIS | 1 0.01 20.32 CHRONIC MYELOID LEUKAEMIA | 2 0.02 20.34 CHRONIC MYELOMONOCYTIC LEUKAEMIA | 1 0.01 20.35 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 7 0.07 20.42 CIRCULATORY COLLAPSE | 7 0.07 20.49 CIRCUMSTANCE OR INFORMATION CAPABLE O.. | 1 0.01 20.50 CITROBACTER INFECTION | 1 0.01 20.51 CLAUSTROPHOBIA | 1 0.01 20.52 CLEFT LIP | 1 0.01 20.53 CLONIC CONVULSION | 1 0.01 20.54 CLONUS | 1 0.01 20.55 CLOSTRIDIUM DIFFICILE COLITIS | 2 0.02 20.57 COAGULATION DISORDER NEONATAL | 1 0.01 20.58 COAGULATION TEST ABNORMAL | 1 0.01 20.59 COAGULATION TIME PROLONGED | 1 0.01 20.60 COAGULOPATHY | 4 0.04 20.64 COARCTATION OF THE AORTA | 1 0.01 20.65 COCCIDIOIDOMYCOSIS | 1 0.01 20.66 COGNITIVE DISORDER | 4 0.04 20.70 COITAL BLEEDING | 1 0.01 20.71 COLD SWEAT | 2 0.02 20.73 COLITIS | 8 0.08 20.81 COLITIS ISCHAEMIC | 1 0.01 20.82 COLITIS ULCERATIVE | 10 0.10 20.92 COLLAPSE OF LUNG | 4 0.04 20.96 COLON CANCER | 3 0.03 20.99 COLON CANCER METASTATIC | 2 0.02 21.01 COLON INJURY | 1 0.01 21.02 COLONIC POLYP | 1 0.01 21.03 COLONOSCOPY ABNORMAL | 1 0.01 21.04 COMA | 11 0.11 21.15 COMA HEPATIC | 1 0.01 21.16 COMMUNICATION DISORDER | 1 0.01 21.17 COMPARTMENT SYNDROME | 1 0.01 21.18 COMPLETED SUICIDE | 9 0.09 21.27 COMPLEX REGIONAL PAIN SYNDROME | 2 0.02 21.29 COMPLICATIONS OF TRANSPLANT SURGERY | 2 0.02 21.31 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 21.32 COMPRESSION FRACTURE | 2 0.02 21.34 COMPUTERISED TOMOGRAM ABNORMAL | 4 0.04 21.38 CONCOMITANT DISEASE AGGRAVATED | 1 0.01 21.39 CONCOMITANT DISEASE PROGRESSION | 3 0.03 21.42 CONCUSSION | 2 0.02 21.44 CONDITION AGGRAVATED | 38 0.38 21.82 CONDUCTION DISORDER | 2 0.02 21.84 CONFUSIONAL STATE | 30 0.30 22.14 CONGENITAL ANOMALY | 1 0.01 22.15 CONGENITAL CENTRAL NERVOUS SYSTEM ANO.. | 1 0.01 22.16 CONGENITAL CYSTIC KIDNEY DISEASE | 1 0.01 22.17 CONGENITAL GENITOURINARY ABNORMALITY | 1 0.01 22.18 CONGENITAL JAW MALFORMATION | 1 0.01 22.19 CONGENITAL JOINT MALFORMATION | 1 0.01 22.20 CONGENITAL NYSTAGMUS | 2 0.02 22.22 CONJUNCTIVAL HAEMORRHAGE | 1 0.01 22.23 CONJUNCTIVAL HYPERAEMIA | 1 0.01 22.24 CONJUNCTIVITIS | 1 0.01 22.25 CONSTIPATION | 32 0.32 22.57 CONTRACTED BLADDER | 10 0.10 22.67 CONTUSION | 8 0.08 22.75 CONVULSION | 51 0.51 23.26 CONVULSION NEONATAL | 1 0.01 23.27 CONVULSIONS LOCAL | 1 0.01 23.28 COOMBS TEST POSITIVE | 1 0.01 23.29 COORDINATION ABNORMAL | 9 0.09 23.38 COPPER DEFICIENCY | 1 0.01 23.39 COR PULMONALE ACUTE | 1 0.01 23.40 CORNEAL EPITHELIUM DEFECT | 1 0.01 23.41 CORNEAL EROSION | 1 0.01 23.42 CORONA VIRUS INFECTION | 1 0.01 23.43 CORONARY ARTERIAL STENT INSERTION | 2 0.02 23.45 CORONARY ARTERY BYPASS | 2 0.02 23.47 CORONARY ARTERY DISEASE | 6 0.06 23.53 CORONARY ARTERY OCCLUSION | 3 0.03 23.56 CORONARY REVASCULARISATION | 2 0.02 23.58 COUGH | 29 0.29 23.87 CRANIOSYNOSTOSIS | 1 0.01 23.88 CREATINE PHOSPHOKINASE DECREASED | 1 0.01 23.89 CREATININE RENAL CLEARANCE | 1 0.01 23.90 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 23.92 CREPITATIONS | 2 0.02 23.94 CREUTZFELDT-JAKOB DISEASE | 1 0.01 23.95 CROHN'S DISEASE | 3 0.03 23.98 CRUSH SYNDROME | 1 0.01 23.99 CRYING | 4 0.04 24.03 CRYOGLOBULINAEMIA | 2 0.02 24.05 CRYSTAL URINE PRESENT | 1 0.01 24.06 CSF GLUCOSE DECREASED | 2 0.02 24.08 CULTURE POSITIVE | 2 0.02 24.10 CULTURE URINE POSITIVE | 4 0.04 24.14 CUSHING'S SYNDROME | 1 0.01 24.15 CYANOSIS | 8 0.08 24.23 CYCLOTHYMIC DISORDER | 1 0.01 24.24 CYST | 3 0.03 24.27 CYST RUPTURE | 1 0.01 24.28 CYSTITIS | 4 0.04 24.32 CYSTITIS HAEMORRHAGIC | 1 0.01 24.33 CYSTITIS INTERSTITIAL | 2 0.02 24.35 CYSTITIS ULCERATIVE | 1 0.01 24.36 CYTOLYTIC HEPATITIS | 2 0.02 24.38 CYTOMEGALOVIRUS INFECTION | 7 0.07 24.45 CYTOMEGALOVIRUS TEST | 1 0.01 24.46 CYTOMEGALOVIRUS TEST POSITIVE | 1 0.01 24.47 DANDY-WALKER SYNDROME | 1 0.01 24.48 DEAFNESS | 3 0.03 24.51 DEAFNESS NEUROSENSORY | 1 0.01 24.52 DEAFNESS UNILATERAL | 1 0.01 24.53 DEATH | 93 0.93 25.46 DEATH NEONATAL | 1 0.01 25.47 DECREASED ACTIVITY | 1 0.01 25.48 DECREASED APPETITE | 7 0.07 25.55 DECUBITUS ULCER | 1 0.01 25.56 DEEP VEIN THROMBOSIS | 12 0.12 25.68 DEFAECATION URGENCY | 2 0.02 25.70 DEHYDRATION | 52 0.52 26.22 DELAYED RECOVERY FROM ANAESTHESIA | 1 0.01 26.23 DELIRIUM | 12 0.12 26.35 DELIVERY | 1 0.01 26.36 DELUSION | 4 0.04 26.40 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 26.41 DEMENTIA | 3 0.03 26.44 DEMYELINATING POLYNEUROPATHY | 1 0.01 26.45 DEMYELINATION | 4 0.04 26.49 DENTAL ALVEOLAR ANOMALY | 1 0.01 26.50 DENTAL CARIES | 9 0.09 26.59 DENTAL CLEANING | 1 0.01 26.60 DENTAL EXAMINATION ABNORMAL | 1 0.01 26.61 DENTAL FISTULA | 1 0.01 26.62 DENTAL NECROSIS | 1 0.01 26.63 DENTAL OPERATION | 3 0.03 26.66 DENTAL TREATMENT | 4 0.04 26.70 DENTURE WEARER | 1 0.01 26.71 DEPENDENCE | 5 0.05 26.76 DEPRESSED LEVEL OF CONSCIOUSNESS | 23 0.23 26.99 DEPRESSED MOOD | 5 0.05 27.04 DEPRESSION | 42 0.42 27.46 DEPRESSION SUICIDAL | 1 0.01 27.47 DEREALISATION | 1 0.01 27.48 DERMATITIS | 6 0.06 27.54 DERMATITIS ALLERGIC | 1 0.01 27.55 DERMATITIS CONTACT | 2 0.02 27.57 DEVELOPMENTAL DELAY | 6 0.06 27.63 DEVICE FAILURE | 1 0.01 27.64 DEVICE INTERACTION | 1 0.01 27.65 DEVICE LEAKAGE | 2 0.02 27.67 DEVICE MALFUNCTION | 4 0.04 27.71 DEVICE RELATED INFECTION | 2 0.02 27.73 DIABETES INSIPIDUS | 4 0.04 27.77 DIABETES MELLITUS | 31 0.31 28.08 DIABETES MELLITUS INADEQUATE CONTROL | 5 0.05 28.13 DIABETIC COMA | 6 0.06 28.19 DIABETIC END STAGE RENAL DISEASE | 1 0.01 28.20 DIABETIC KETOACIDOSIS | 6 0.06 28.26 DIABETIC NEPHROPATHY | 2 0.02 28.28 DIABETIC NEUROPATHY | 1 0.01 28.29 DIABETIC RETINOPATHY | 2 0.02 28.31 DIALYSIS | 12 0.12 28.43 DIAPHRAGMATIC HERNIA | 1 0.01 28.44 DIAPHRAGMATIC RUPTURE | 2 0.02 28.46 DIARRHOEA | 85 0.85 29.31 DIARRHOEA HAEMORRHAGIC | 6 0.06 29.37 DILATATION VENTRICULAR | 1 0.01 29.38 DIPLOPIA | 6 0.06 29.44 DISCOMFORT | 4 0.04 29.48 DISEASE PROGRESSION | 18 0.18 29.66 DISEASE RECURRENCE | 2 0.02 29.68 DISLOCATION OF JOINT PROSTHESIS | 1 0.01 29.69 DISORDER OF ORBIT | 1 0.01 29.70 DISORIENTATION | 18 0.18 29.88 DISSEMINATED INTRAVASCULAR COAGULATION | 11 0.11 29.99 DISSEMINATED TUBERCULOSIS | 2 0.02 30.01 DISSOCIATION | 3 0.03 30.04 DISTRACTIBILITY | 1 0.01 30.05 DISTURBANCE IN ATTENTION | 5 0.05 30.10 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 30.11 DIVERTICULAR PERFORATION | 3 0.03 30.14 DIVERTICULITIS | 5 0.05 30.19 DIVERTICULUM | 1 0.01 30.20 DIVERTICULUM INTESTINAL | 1 0.01 30.21 DIZZINESS | 71 0.71 30.92 DOCUMENTED HYPERSENSITIVITY TO ADMINI.. | 1 0.01 30.93 DROOLING | 2 0.02 30.95 DRUG ABUSER | 18 0.18 31.13 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 1 0.01 31.14 DRUG ADMINISTRATION ERROR | 3 0.03 31.17 DRUG DEPENDENCE | 6 0.06 31.23 DRUG DISPENSING ERROR | 1 0.01 31.24 DRUG DOSE OMISSION | 5 0.05 31.29 DRUG EFFECT DECREASED | 11 0.11 31.40 DRUG ERUPTION | 12 0.12 31.52 DRUG EXPOSURE BEFORE PREGNANCY | 2 0.02 31.54 DRUG EXPOSURE DURING PREGNANCY | 55 0.55 32.09 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 32.10 DRUG HYPERSENSITIVITY | 12 0.12 32.22 DRUG INEFFECTIVE | 99 0.99 33.21 DRUG INEFFECTIVE FOR UNAPPROVED INDIC.. | 3 0.03 33.24 DRUG INTERACTION | 57 0.57 33.81 DRUG INTERACTION INHIBITION | 1 0.01 33.82 DRUG INTERACTION POTENTIATION | 2 0.02 33.84 DRUG INTOLERANCE | 3 0.03 33.87 DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 33.88 DRUG LEVEL INCREASED | 5 0.05 33.93 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 3 0.03 33.96 DRUG RESISTANCE | 6 0.06 34.02 DRUG SCREEN FALSE POSITIVE | 1 0.01 34.03 DRUG SCREEN POSITIVE | 1 0.01 34.04 DRUG SPECIFIC ANTIBODY PRESENT | 1 0.01 34.05 DRUG TOXICITY | 8 0.08 34.13 DRUG WITHDRAWAL SYNDROME | 19 0.19 34.32 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 34.33 DRY EYE | 4 0.04 34.37 DRY MOUTH | 14 0.14 34.51 DRY SKIN | 5 0.05 34.56 DRY THROAT | 1 0.01 34.57 DUODENAL OPERATION | 1 0.01 34.58 DUODENAL PERFORATION | 1 0.01 34.59 DUODENAL ULCER | 1 0.01 34.60 DUODENAL ULCER HAEMORRHAGE | 2 0.02 34.62 DUODENAL ULCER PERFORATION | 1 0.01 34.63 DUODENITIS | 2 0.02 34.65 DYSAESTHESIA | 1 0.01 34.66 DYSARTHRIA | 9 0.09 34.75 DYSENTERY | 1 0.01 34.76 DYSGEUSIA | 8 0.08 34.84 DYSKINESIA | 9 0.09 34.93 DYSKINESIA NEONATAL | 1 0.01 34.94 DYSMENORRHOEA | 1 0.01 34.95 DYSMORPHISM | 2 0.02 34.97 DYSPAREUNIA | 1 0.01 34.98 DYSPEPSIA | 9 0.09 35.07 DYSPHAGIA | 15 0.15 35.22 DYSPHEMIA | 1 0.01 35.23 DYSPHONIA | 4 0.04 35.27 DYSPLASIA | 1 0.01 35.28 DYSPNOEA | 101 1.01 36.29 DYSPNOEA EXERTIONAL | 4 0.04 36.33 DYSPRAXIA | 1 0.01 36.34 DYSSTASIA | 3 0.03 36.37 DYSTONIA | 3 0.03 36.40 DYSURIA | 12 0.12 36.52 EAR DISCOMFORT | 1 0.01 36.53 EAR MALFORMATION | 1 0.01 36.54 EAR PRURITUS | 1 0.01 36.55 EATING DISORDER | 6 0.06 36.61 EATING DISORDER SYMPTOM | 1 0.01 36.62 ECCHYMOSIS | 2 0.02 36.64 ECHOCARDIOGRAM ABNORMAL | 2 0.02 36.66 ECHOCARDIOGRAM NORMAL | 1 0.01 36.67 ECONOMIC PROBLEM | 2 0.02 36.69 ECZEMA | 2 0.02 36.71 EJACULATION FAILURE | 1 0.01 36.72 EJECTION FRACTION DECREASED | 6 0.06 36.78 ELECTROCARDIOGRAM ABNORMAL | 4 0.04 36.82 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 36.83 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL | 1 0.01 36.84 ELECTROCARDIOGRAM QT PROLONGED | 5 0.05 36.89 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 1 0.01 36.90 ELECTROCARDIOGRAM T WAVE ABNORMAL | 1 0.01 36.91 ELECTROENCEPHALOGRAM ABNORMAL | 1 0.01 36.92 ELECTROLYTE IMBALANCE | 6 0.06 36.98 EMBOLIC STROKE | 3 0.03 37.01 EMBOLISM | 2 0.02 37.03 EMBOLISM VENOUS | 3 0.03 37.06 EMOTIONAL DISORDER | 3 0.03 37.09 EMOTIONAL DISTRESS | 5 0.05 37.14 EMPYEMA | 1 0.01 37.15 ENAMEL ANOMALY | 1 0.01 37.16 ENCEPHALITIS | 1 0.01 37.17 ENCEPHALOMALACIA | 1 0.01 37.18 ENCEPHALOPATHY | 6 0.06 37.24 ENDOCARDITIS | 1 0.01 37.25 ENDOCARDITIS BACTERIAL | 1 0.01 37.26 ENDODONTIC PROCEDURE | 3 0.03 37.29 ENDOMETRIAL DISORDER | 1 0.01 37.30 ENDOMETRIOSIS | 1 0.01 37.31 ENDOMETRITIS | 1 0.01 37.32 ENDOPHTHALMITIS | 1 0.01 37.33 ENDOSCOPIC RETROGRADE CHOLANGIOPANCRE.. | 1 0.01 37.34 ENDOSCOPY SMALL INTESTINE | 1 0.01 37.35 ENDOSCOPY UPPER GASTROINTESTINAL TRAC.. | 1 0.01 37.36 ENTERITIS | 2 0.02 37.38 ENTEROBACTER INFECTION | 1 0.01 37.39 ENTEROCOCCAL INFECTION | 1 0.01 37.40 ENTEROCOCCAL SEPSIS | 1 0.01 37.41 ENTEROCOLITIS | 3 0.03 37.44 ENTEROCOLITIS HAEMORRHAGIC | 1 0.01 37.45 ENZYME ABNORMALITY | 1 0.01 37.46 EOSINOPHIL COUNT DECREASED | 2 0.02 37.48 EOSINOPHILIA | 4 0.04 37.52 EOSINOPHILIC PNEUMONIA | 1 0.01 37.53 EPIGASTRIC DISCOMFORT | 1 0.01 37.54 EPILEPSY | 8 0.08 37.62 EPIPHYSEAL INJURY | 1 0.01 37.63 EPIPLOIC APPENDAGITIS | 1 0.01 37.64 EPISTAXIS | 12 0.12 37.76 EPSTEIN-BARR VIRUS ANTIBODY POSITIVE | 1 0.01 37.77 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 37.79 ERECTILE DYSFUNCTION | 2 0.02 37.81 ERECTION INCREASED | 1 0.01 37.82 EROSIVE DUODENITIS | 1 0.01 37.83 EROSIVE OESOPHAGITIS | 2 0.02 37.85 ERUCTATION | 3 0.03 37.88 ERYSIPELAS | 1 0.01 37.89 ERYTHEMA | 26 0.26 38.15 ERYTHEMA ANNULARE | 1 0.01 38.16 ERYTHEMA DYSCHROMICUM PERSTANS | 1 0.01 38.17 ERYTHEMA INFECTIOSUM | 1 0.01 38.18 ERYTHEMA MULTIFORME | 3 0.03 38.21 ERYTHEMA OF EYELID | 1 0.01 38.22 ERYTHROBLASTOSIS | 1 0.01 38.23 ERYTHROPOIESIS ABNORMAL | 1 0.01 38.24 ESCHERICHIA BACTERAEMIA | 1 0.01 38.25 ESCHERICHIA INFECTION | 2 0.02 38.27 ESCHERICHIA URINARY TRACT INFECTION | 1 0.01 38.28 ESSENTIAL HYPERTENSION | 1 0.01 38.29 EUPHORIC MOOD | 2 0.02 38.31 EWING'S SARCOMA | 1 0.01 38.32 EXCESSIVE GRANULATION TISSUE | 1 0.01 38.33 EXCESSIVE MASTURBATION | 1 0.01 38.34 EXCORIATION | 1 0.01 38.35 EXHIBITIONISM | 1 0.01 38.36 EXOPHTHALMOS | 2 0.02 38.38 EXOSTOSIS | 2 0.02 38.40 EXPIRED DRUG ADMINISTERED | 1 0.01 38.41 EXPLORATIVE LAPAROTOMY | 1 0.01 38.42 EXTRAPYRAMIDAL DISORDER | 5 0.05 38.47 EXTRASYSTOLES | 5 0.05 38.52 EXTREMITY NECROSIS | 1 0.01 38.53 EYE DISORDER | 5 0.05 38.58 EYE EXCISION | 1 0.01 38.59 EYE HAEMORRHAGE | 4 0.04 38.63 EYE INFECTION | 1 0.01 38.64 EYE INFECTION SYPHILITIC | 1 0.01 38.65 EYE INJURY | 1 0.01 38.66 EYE IRRITATION | 5 0.05 38.71 EYE MOVEMENT DISORDER | 1 0.01 38.72 EYE OEDEMA | 1 0.01 38.73 EYE OPERATION | 1 0.01 38.74 EYE PAIN | 7 0.07 38.81 EYE PRURITUS | 2 0.02 38.83 EYE ROLLING | 2 0.02 38.85 EYE SWELLING | 2 0.02 38.87 EYELID OEDEMA | 1 0.01 38.88 FACE OEDEMA | 4 0.04 38.92 FACE PRESENTATION | 1 0.01 38.93 FACIAL PALSY | 4 0.04 38.97 FACIAL PARESIS | 2 0.02 38.99 FACTOR VIII INHIBITION | 2 0.02 39.01 FAECAL INCONTINENCE | 5 0.05 39.06 FAECALOMA | 1 0.01 39.07 FAECES DISCOLOURED | 4 0.04 39.11 FAECES HARD | 1 0.01 39.12 FAILURE OF CHILD RESISTANT MECHANISM .. | 1 0.01 39.13 FAILURE TO THRIVE | 2 0.02 39.15 FALL | 58 0.58 39.73 FALLOPIAN TUBE CYST | 1 0.01 39.74 FALLOPIAN TUBE DISORDER | 1 0.01 39.75 FALLOPIAN TUBE OPERATION | 1 0.01 39.76 FAMILIAL MEDITERRANEAN FEVER | 1 0.01 39.77 FANCONI SYNDROME ACQUIRED | 1 0.01 39.78 FASCIITIS | 1 0.01 39.79 FAT EMBOLISM | 1 0.01 39.80 FAT TISSUE INCREASED | 1 0.01 39.81 FATIGUE | 70 0.70 40.51 FEAR | 1 0.01 40.52 FEAR OF PREGNANCY | 1 0.01 40.53 FEBRILE BONE MARROW APLASIA | 2 0.02 40.55 FEBRILE NEUTROPENIA | 16 0.16 40.71 FEEDING DISORDER | 1 0.01 40.72 FEEDING DISORDER NEONATAL | 1 0.01 40.73 FEEDING TUBE COMPLICATION | 1 0.01 40.74 FEELING ABNORMAL | 25 0.25 40.99 FEELING COLD | 5 0.05 41.04 FEELING HOT | 4 0.04 41.08 FEELING JITTERY | 2 0.02 41.10 FEELING OF BODY TEMPERATURE CHANGE | 2 0.02 41.12 FEELING OF DESPAIR | 1 0.01 41.13 FEMORAL ARTERIAL STENOSIS | 1 0.01 41.14 FEMORAL ARTERY OCCLUSION | 1 0.01 41.15 FEMORAL NECK FRACTURE | 3 0.03 41.18 FEMUR FRACTURE | 3 0.03 41.21 FIBROCYSTIC BREAST DISEASE | 1 0.01 41.22 FIBROMA | 1 0.01 41.23 FIBROMUSCULAR DYSPLASIA | 1 0.01 41.24 FIBROMYALGIA | 1 0.01 41.25 FIBROSIS | 1 0.01 41.26 FISTULA | 4 0.04 41.30 FLANK PAIN | 1 0.01 41.31 FLATULENCE | 8 0.08 41.39 FLOPPY IRIS SYNDROME | 1 0.01 41.40 FLUID INTAKE REDUCED | 2 0.02 41.42 FLUID OVERLOAD | 3 0.03 41.45 FLUID RETENTION | 9 0.09 41.54 FLUSHING | 7 0.07 41.61 FOETAL GROWTH RETARDATION | 3 0.03 41.64 FOETAL-MATERNAL HAEMORRHAGE | 1 0.01 41.65 FOLATE DEFICIENCY | 1 0.01 41.66 FOOD INTOLERANCE | 1 0.01 41.67 FOOD POISONING | 2 0.02 41.69 FOOT AMPUTATION | 1 0.01 41.70 FOOT FRACTURE | 3 0.03 41.73 FOOT OPERATION | 3 0.03 41.76 FORCEPS DELIVERY | 1 0.01 41.77 FORMICATION | 2 0.02 41.79 FRACTURE | 3 0.03 41.82 FRACTURE DELAYED UNION | 1 0.01 41.83 FRACTURE NONUNION | 1 0.01 41.84 FRACTURED COCCYX | 1 0.01 41.85 FREEZING PHENOMENON | 1 0.01 41.86 FRUSTRATION | 1 0.01 41.87 FULL BLOOD COUNT ABNORMAL | 1 0.01 41.88 FUNGAEMIA | 1 0.01 41.89 FUNGAL INFECTION | 6 0.06 41.95 FUNGUS SPUTUM TEST POSITIVE | 1 0.01 41.96 GAIT DISTURBANCE | 21 0.21 42.17 GALACTORRHOEA | 1 0.01 42.18 GALLBLADDER DISORDER | 3 0.03 42.21 GALLBLADDER OPERATION | 1 0.01 42.22 GAMBLING | 2 0.02 42.24 GAMMA-GLUTAMYLTRANSFERASE DECREASED | 1 0.01 42.25 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 15 0.15 42.40 GAMMOPATHY | 1 0.01 42.41 GANGRENE | 2 0.02 42.43 GASTRIC BYPASS | 2 0.02 42.45 GASTRIC CANCER | 4 0.04 42.49 GASTRIC DISORDER | 5 0.05 42.54 GASTRIC HAEMORRHAGE | 4 0.04 42.58 GASTRIC NEOPLASM | 1 0.01 42.59 GASTRIC ULCER | 5 0.05 42.64 GASTRIC VARICES HAEMORRHAGE | 1 0.01 42.65 GASTRITIS | 9 0.09 42.74 GASTRITIS EROSIVE | 3 0.03 42.77 GASTROENTERITIS | 8 0.08 42.85 GASTROENTERITIS ESCHERICHIA COLI | 1 0.01 42.86 GASTROENTERITIS RADIATION | 1 0.01 42.87 GASTROENTERITIS SALMONELLA | 1 0.01 42.88 GASTROENTERITIS VIRAL | 2 0.02 42.90 GASTROINTESTINAL DISORDER | 10 0.10 43.00 GASTROINTESTINAL EROSION | 2 0.02 43.02 GASTROINTESTINAL FUNGAL INFECTION | 1 0.01 43.03 GASTROINTESTINAL HAEMORRHAGE | 14 0.14 43.17 GASTROINTESTINAL INFECTION | 4 0.04 43.21 GASTROINTESTINAL INJURY | 1 0.01 43.22 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 43.24 GASTROINTESTINAL NECROSIS | 4 0.04 43.28 GASTROINTESTINAL PAIN | 1 0.01 43.29 GASTROINTESTINAL SOUNDS ABNORMAL | 1 0.01 43.30 GASTROINTESTINAL STROMAL TUMOUR | 1 0.01 43.31 GASTROINTESTINAL TUBE INSERTION | 1 0.01 43.32 GASTROOESOPHAGEAL REFLUX DISEASE | 13 0.13 43.45 GENERAL ANAESTHESIA | 1 0.01 43.46 GENERAL PHYSICAL CONDITION ABNORMAL | 2 0.02 43.48 GENERAL PHYSICAL HEALTH DETERIORATION | 24 0.24 43.72 GENERALISED ERYTHEMA | 6 0.06 43.78 GENERALISED OEDEMA | 4 0.04 43.82 GENITAL HERPES | 1 0.01 43.83 GESTATIONAL DIABETES | 2 0.02 43.85 GINGIVAL BLEEDING | 2 0.02 43.87 GINGIVAL DISORDER | 2 0.02 43.89 GINGIVAL EROSION | 1 0.01 43.90 GINGIVAL HYPERPLASIA | 1 0.01 43.91 GINGIVAL INFECTION | 1 0.01 43.92 GINGIVAL PAIN | 3 0.03 43.95 GINGIVAL SWELLING | 2 0.02 43.97 GINGIVAL ULCERATION | 2 0.02 43.99 GINGIVITIS | 8 0.08 44.07 GLASGOW COMA SCALE ABNORMAL | 1 0.01 44.08 GLAUCOMA | 1 0.01 44.09 GLIOBLASTOMA | 1 0.01 44.10 GLIOBLASTOMA MULTIFORME | 1 0.01 44.11 GLIOMA | 1 0.01 44.12 GLOBAL AMNESIA | 1 0.01 44.13 GLOMERULAR FILTRATION RATE DECREASED | 1 0.01 44.14 GLOMERULONEPHRITIS ACUTE | 1 0.01 44.15 GLOMERULONEPHRITIS CHRONIC | 1 0.01 44.16 GLOMERULONEPHROPATHY | 1 0.01 44.17 GLOMERULOSCLEROSIS | 1 0.01 44.18 GLOSSITIS | 2 0.02 44.20 GLOSSODYNIA | 1 0.01 44.21 GLOSSOPTOSIS | 1 0.01 44.22 GLUCOSE TOLERANCE DECREASED | 1 0.01 44.23 GLYCOSYLATED HAEMOGLOBIN INCREASED | 4 0.04 44.27 GOITRE | 1 0.01 44.28 GOUT | 1 0.01 44.29 GOUTY ARTHRITIS | 1 0.01 44.30 GRAFT COMPLICATION | 1 0.01 44.31 GRAFT DELAMINATION | 1 0.01 44.32 GRAFT THROMBOSIS | 1 0.01 44.33 GRAFT VERSUS HOST DISEASE | 3 0.03 44.36 GRAND MAL CONVULSION | 6 0.06 44.42 GRANULOCYTOPENIA | 1 0.01 44.43 GRANULOMA | 1 0.01 44.44 GROIN ABSCESS | 1 0.01 44.45 GROIN PAIN | 1 0.01 44.46 GROWTH RETARDATION | 1 0.01 44.47 GRUNTING | 1 0.01 44.48 GUILLAIN-BARRE SYNDROME | 1 0.01 44.49 GUN SHOT WOUND | 1 0.01 44.50 GYNAECOMASTIA | 6 0.06 44.56 HAEMANGIOMA | 1 0.01 44.57 HAEMARTHROSIS | 1 0.01 44.58 HAEMATEMESIS | 13 0.13 44.71 HAEMATOCHEZIA | 10 0.10 44.81 HAEMATOCRIT DECREASED | 10 0.10 44.91 HAEMATOCRIT INCREASED | 1 0.01 44.92 HAEMATOMA | 7 0.07 44.99 HAEMATOMA INFECTION | 1 0.01 45.00 HAEMATURIA | 21 0.21 45.21 HAEMOCONCENTRATION | 1 0.01 45.22 HAEMODIALYSIS | 6 0.06 45.28 HAEMODYNAMIC INSTABILITY | 1 0.01 45.29 HAEMODYNAMIC TEST ABNORMAL | 1 0.01 45.30 HAEMOGLOBIN DECREASED | 41 0.41 45.71 HAEMOLYSIS | 2 0.02 45.73 HAEMOLYTIC ANAEMIA | 3 0.03 45.76 HAEMOPHILUS INFECTION | 1 0.01 45.77 HAEMOPTYSIS | 7 0.07 45.84 HAEMORRHAGE | 15 0.15 45.99 HAEMORRHAGE INTRACRANIAL | 6 0.06 46.05 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 46.06 HAEMORRHAGE URINARY TRACT | 2 0.02 46.08 HAEMORRHAGIC OVARIAN CYST | 1 0.01 46.09 HAEMORRHAGIC STROKE | 1 0.01 46.10 HAEMORRHOID OPERATION | 1 0.01 46.11 HAEMORRHOIDAL HAEMORRHAGE | 2 0.02 46.13 HAEMORRHOIDS | 8 0.08 46.21 HAEMOSIDEROSIS | 1 0.01 46.22 HAEMOSTASIS | 1 0.01 46.23 HALLUCINATION | 18 0.18 46.41 HALLUCINATION, AUDITORY | 2 0.02 46.43 HALLUCINATION, VISUAL | 6 0.06 46.49 HAND FRACTURE | 2 0.02 46.51 HANGOVER | 1 0.01 46.52 HEAD DISCOMFORT | 2 0.02 46.54 HEAD INJURY | 4 0.04 46.58 HEADACHE | 76 0.76 47.34 HEARING IMPAIRED | 2 0.02 47.36 HEART DISEASE CONGENITAL | 3 0.03 47.39 HEART INJURY | 1 0.01 47.40 HEART RATE ABNORMAL | 3 0.03 47.43 HEART RATE DECREASED | 2 0.02 47.45 HEART RATE INCREASED | 19 0.19 47.64 HEART RATE IRREGULAR | 7 0.07 47.71 HEAT EXHAUSTION | 1 0.01 47.72 HEAT STROKE | 1 0.01 47.73 HELICOBACTER INFECTION | 1 0.01 47.74 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 47.75 HEMIANOPIA HOMONYMOUS | 1 0.01 47.76 HEMIPARESIS | 8 0.08 47.84 HEMIPLEGIA | 9 0.09 47.93 HENOCH-SCHONLEIN PURPURA | 4 0.04 47.97 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 47.99 HEPATECTOMY | 1 0.01 48.00 HEPATIC CIRRHOSIS | 4 0.04 48.04 HEPATIC CYST INFECTION | 1 0.01 48.05 HEPATIC EMBOLISATION | 1 0.01 48.06 HEPATIC ENCEPHALOPATHY | 4 0.04 48.10 HEPATIC ENZYME INCREASED | 9 0.09 48.19 HEPATIC FAILURE | 13 0.13 48.32 HEPATIC FIBROSIS | 1 0.01 48.33 HEPATIC FUNCTION ABNORMAL | 12 0.12 48.45 HEPATIC NECROSIS | 2 0.02 48.47 HEPATIC NEOPLASM MALIGNANT | 2 0.02 48.49 HEPATIC PAIN | 2 0.02 48.51 HEPATIC STEATOSIS | 10 0.10 48.61 HEPATIC VEIN OCCLUSION | 1 0.01 48.62 HEPATITIS | 17 0.17 48.79 HEPATITIS A | 2 0.02 48.81 HEPATITIS A ANTIBODY POSITIVE | 1 0.01 48.82 HEPATITIS ACUTE | 2 0.02 48.84 HEPATITIS B DNA ASSAY POSITIVE | 2 0.02 48.86 HEPATITIS C | 4 0.04 48.90 HEPATITIS C ANTIBODY POSITIVE | 1 0.01 48.91 HEPATITIS CHOLESTATIC | 1 0.01 48.92 HEPATITIS FULMINANT | 2 0.02 48.94 HEPATITIS TOXIC | 3 0.03 48.97 HEPATITIS VIRAL | 1 0.01 48.98 HEPATOCELLULAR DAMAGE | 2 0.02 49.00 HEPATOMEGALY | 3 0.03 49.03 HEPATORENAL SYNDROME | 1 0.01 49.04 HEPATOSPLENOMEGALY | 2 0.02 49.06 HEPATOTOXICITY | 3 0.03 49.09 HERNIA | 4 0.04 49.13 HERNIA REPAIR | 1 0.01 49.14 HERPES ZOSTER | 6 0.06 49.20 HIATUS HERNIA | 6 0.06 49.26 HIGH ARCHED PALATE | 1 0.01 49.27 HIGH DENSITY LIPOPROTEIN | 1 0.01 49.28 HILAR LYMPHADENOPATHY | 1 0.01 49.29 HIP DYSPLASIA | 3 0.03 49.32 HIP FRACTURE | 10 0.10 49.42 HISTIOCYTOSIS HAEMATOPHAGIC | 1 0.01 49.43 HISTOLOGY ABNORMAL | 1 0.01 49.44 HISTRIONIC PERSONALITY DISORDER | 1 0.01 49.45 HIV ANTIBODY POSITIVE | 1 0.01 49.46 HOMICIDAL IDEATION | 2 0.02 49.48 HOMICIDE | 1 0.01 49.49 HORDEOLUM | 1 0.01 49.50 HOSPITALISATION | 6 0.06 49.56 HOSTILITY | 1 0.01 49.57 HOT FLUSH | 9 0.09 49.66 HUMERUS FRACTURE | 1 0.01 49.67 HYDROCEPHALUS | 1 0.01 49.68 HYDRONEPHROSIS | 11 0.11 49.79 HYDROPS FOETALIS | 1 0.01 49.80 HYDROURETER | 1 0.01 49.81 HYPERACUSIS | 2 0.02 49.83 HYPERBARIC OXYGEN THERAPY | 1 0.01 49.84 HYPERBILIRUBINAEMIA | 3 0.03 49.87 HYPERBILIRUBINAEMIA NEONATAL | 1 0.01 49.88 HYPERCALCAEMIA | 4 0.04 49.92 HYPERCAPNIA | 2 0.02 49.94 HYPERCHOLESTEROLAEMIA | 1 0.01 49.95 HYPERGLYCAEMIA | 12 0.12 50.07 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTI.. | 1 0.01 50.08 HYPERHIDROSIS | 20 0.20 50.28 HYPERKALAEMIA | 19 0.19 50.47 HYPERKERATOSIS | 1 0.01 50.48 HYPERKINESIA | 2 0.02 50.50 HYPERLIPIDAEMIA | 3 0.03 50.53 HYPERMETROPIA | 2 0.02 50.55 HYPERNATRAEMIA | 2 0.02 50.57 HYPERPHAGIA | 1 0.01 50.58 HYPERPROLACTINAEMIA | 3 0.03 50.61 HYPERREFLEXIA | 1 0.01 50.62 HYPERSENSITIVITY | 15 0.15 50.77 HYPERSEXUALITY | 2 0.02 50.79 HYPERSOMNIA | 6 0.06 50.85 HYPERTENSION | 35 0.35 51.20 HYPERTENSIVE CRISIS | 1 0.01 51.21 HYPERTHERMIA | 3 0.03 51.24 HYPERTHERMIA MALIGNANT | 1 0.01 51.25 HYPERTONIA | 3 0.03 51.28 HYPERTONIC BLADDER | 1 0.01 51.29 HYPERTRICHOSIS | 1 0.01 51.30 HYPERTRIGLYCERIDAEMIA | 2 0.02 51.32 HYPERTROPHIC OSTEOARTHROPATHY | 1 0.01 51.33 HYPERTROPHY | 2 0.02 51.35 HYPERURICAEMIA | 1 0.01 51.36 HYPERVENTILATION | 4 0.04 51.40 HYPERVIGILANCE | 1 0.01 51.41 HYPOAESTHESIA | 34 0.34 51.75 HYPOAESTHESIA FACIAL | 2 0.02 51.77 HYPOAESTHESIA ORAL | 2 0.02 51.79 HYPOALBUMINAEMIA | 3 0.03 51.82 HYPOCALCAEMIA | 4 0.04 51.86 HYPOCOMPLEMENTAEMIA | 1 0.01 51.87 HYPOGAMMAGLOBULINAEMIA | 2 0.02 51.89 HYPOGEUSIA | 1 0.01 51.90 HYPOGLYCAEMIA | 18 0.18 52.08 HYPOGLYCAEMIA NEONATAL | 4 0.04 52.12 HYPOGLYCAEMIC COMA | 1 0.01 52.13 HYPOGLYCAEMIC UNCONSCIOUSNESS | 1 0.01 52.14 HYPOKALAEMIA | 13 0.13 52.27 HYPOKINESIA | 2 0.02 52.29 HYPOMAGNESAEMIA | 1 0.01 52.30 HYPOMANIA | 2 0.02 52.32 HYPONATRAEMIA | 22 0.22 52.54 HYPOPARATHYROIDISM | 1 0.01 52.55 HYPOPHOSPHATAEMIA | 1 0.01 52.56 HYPOPROTEINAEMIA | 1 0.01 52.57 HYPOPYON | 1 0.01 52.58 HYPOTENSION | 39 0.39 52.97 HYPOTHERMIA | 2 0.02 52.99 HYPOTHYROIDISM | 10 0.10 53.09 HYPOTONIA | 2 0.02 53.11 HYPOTONIC URINARY BLADDER | 1 0.01 53.12 HYPOTRICHOSIS | 1 0.01 53.13 HYPOVENTILATION | 2 0.02 53.15 HYPOVOLAEMIA | 4 0.04 53.19 HYPOXIA | 11 0.11 53.30 HYSTERECTOMY | 2 0.02 53.32 IATROGENIC INFECTION | 3 0.03 53.35 IATROGENIC INJURY | 2 0.02 53.37 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 3 0.03 53.40 ILEITIS | 1 0.01 53.41 ILEOSTOMY CLOSURE | 1 0.01 53.42 ILEUS | 4 0.04 53.46 ILEUS PARALYTIC | 1 0.01 53.47 ILL-DEFINED DISORDER | 7 0.07 53.54 IMMOBILE | 1 0.01 53.55 IMMUNE RECONSTITUTION SYNDROME | 4 0.04 53.59 IMMUNE SYSTEM DISORDER | 2 0.02 53.61 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 3 0.03 53.64 IMPAIRED DRIVING ABILITY | 1 0.01 53.65 IMPAIRED GASTRIC EMPTYING | 2 0.02 53.67 IMPAIRED HEALING | 7 0.07 53.74 IMPAIRED WORK ABILITY | 1 0.01 53.75 IMPLANT SITE PAIN | 1 0.01 53.76 INADEQUATE ANALGESIA | 2 0.02 53.78 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 10 0.10 53.88 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 2 0.02 53.90 INCISION SITE COMPLICATION | 1 0.01 53.91 INCOHERENT | 3 0.03 53.94 INCONTINENCE | 3 0.03 53.97 INCORRECT DOSE ADMINISTERED | 11 0.11 54.08 INCORRECT DRUG ADMINISTRATION DURATION | 6 0.06 54.14 INCORRECT DRUG ADMINISTRATION RATE | 2 0.02 54.16 INCORRECT ROUTE OF DRUG ADMINISTRATION | 1 0.01 54.17 INCREASED APPETITE | 1 0.01 54.18 INCREASED BRONCHIAL SECRETION | 1 0.01 54.19 INCREASED TENDENCY TO BRUISE | 1 0.01 54.20 INCREASED UPPER AIRWAY SECRETION | 2 0.02 54.22 INDURATION | 1 0.01 54.23 INFANTILE APNOEIC ATTACK | 2 0.02 54.25 INFANTILE SPASMS | 1 0.01 54.26 INFECTION | 13 0.13 54.39 INFLAMMATION | 11 0.11 54.50 INFLAMMATORY BOWEL DISEASE | 6 0.06 54.56 INFLUENZA | 5 0.05 54.61 INFLUENZA LIKE ILLNESS | 12 0.12 54.73 INFREQUENT BOWEL MOVEMENTS | 1 0.01 54.74 INFUSION RELATED REACTION | 6 0.06 54.80 INFUSION SITE EXTRAVASATION | 1 0.01 54.81 INFUSION SITE INFLAMMATION | 1 0.01 54.82 INFUSION SITE PAIN | 1 0.01 54.83 INFUSION SITE REACTION | 1 0.01 54.84 INGROWN HAIR | 1 0.01 54.85 INITIAL INSOMNIA | 1 0.01 54.86 INJECTION SITE ABSCESS | 1 0.01 54.87 INJECTION SITE BRUISING | 2 0.02 54.89 INJECTION SITE DISCOLOURATION | 1 0.01 54.90 INJECTION SITE EROSION | 1 0.01 54.91 INJECTION SITE ERYTHEMA | 5 0.05 54.96 INJECTION SITE HAEMORRHAGE | 1 0.01 54.97 INJECTION SITE INFECTION | 1 0.01 54.98 INJECTION SITE IRRITATION | 3 0.03 55.01 INJECTION SITE MASS | 1 0.01 55.02 INJECTION SITE PAIN | 8 0.08 55.10 INJECTION SITE PRURITUS | 1 0.01 55.11 INJECTION SITE PUSTULE | 2 0.02 55.13 INJECTION SITE RASH | 1 0.01 55.14 INJECTION SITE REACTION | 2 0.02 55.16 INJECTION SITE SWELLING | 1 0.01 55.17 INJECTION SITE ULCER | 1 0.01 55.18 INJECTION SITE WARMTH | 1 0.01 55.19 INJURY | 7 0.07 55.26 INJURY CORNEAL | 1 0.01 55.27 INSOMNIA | 40 0.40 55.67 INTENTIONAL DRUG MISUSE | 5 0.05 55.72 INTENTIONAL OVERDOSE | 10 0.10 55.82 INTENTIONAL SELF-INJURY | 2 0.02 55.84 INTERCEPTED DRUG ADMINISTRATION ERROR | 1 0.01 55.85 INTERCOSTAL NEURALGIA | 2 0.02 55.87 INTERCOSTAL RETRACTION | 2 0.02 55.89 INTERMITTENT CLAUDICATION | 1 0.01 55.90 INTERNATIONAL NORMALISED RATIO INCREA.. | 12 0.12 56.02 INTERRUPTION OF AORTIC ARCH | 1 0.01 56.03 INTERSTITIAL LUNG DISEASE | 11 0.11 56.14 INTERVERTEBRAL DISC DISORDER | 2 0.02 56.16 INTERVERTEBRAL DISC INJURY | 2 0.02 56.18 INTERVERTEBRAL DISC OPERATION | 1 0.01 56.19 INTERVERTEBRAL DISC PROTRUSION | 6 0.06 56.25 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 56.26 INTESTINAL HAEMORRHAGE | 4 0.04 56.30 INTESTINAL ISCHAEMIA | 1 0.01 56.31 INTESTINAL MALROTATION | 1 0.01 56.32 INTESTINAL OBSTRUCTION | 11 0.11 56.43 INTESTINAL OPERATION | 1 0.01 56.44 INTESTINAL PERFORATION | 2 0.02 56.46 INTESTINAL RESECTION | 3 0.03 56.49 INTESTINAL ULCER | 2 0.02 56.51 INTRA-ABDOMINAL HAEMATOMA | 2 0.02 56.53 INTRA-UTERINE DEATH | 4 0.04 56.57 INTRACARDIAC THROMBUS | 3 0.03 56.60 INTRACRANIAL ANEURYSM | 4 0.04 56.64 INTRACRANIAL PRESSURE INCREASED | 3 0.03 56.67 INTRACRANIAL VENOUS SINUS THROMBOSIS | 2 0.02 56.69 INTRAOCULAR PRESSURE INCREASED | 5 0.05 56.74 INTRAVENTRICULAR HAEMORRHAGE | 2 0.02 56.76 IRON BINDING CAPACITY TOTAL INCREASED | 1 0.01 56.77 IRRITABILITY | 10 0.10 56.87 IRRITABLE BOWEL SYNDROME | 10 0.10 56.97 ISCHAEMIA | 1 0.01 56.98 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 56.99 ISCHAEMIC STROKE | 4 0.04 57.03 JAUNDICE | 11 0.11 57.14 JAUNDICE NEONATAL | 2 0.02 57.16 JAW DISORDER | 4 0.04 57.20 JAW FRACTURE | 1 0.01 57.21 JC VIRUS INFECTION | 1 0.01 57.22 JEALOUS DELUSION | 1 0.01 57.23 JOINT CREPITATION | 1 0.01 57.24 JOINT DISLOCATION | 1 0.01 57.25 JOINT INJURY | 4 0.04 57.29 JOINT RANGE OF MOTION DECREASED | 2 0.02 57.31 JOINT SURGERY | 1 0.01 57.32 JOINT SWELLING | 7 0.07 57.39 KAPOSI'S SARCOMA | 1 0.01 57.40 KERATITIS | 1 0.01 57.41 KERATITIS BACTERIAL | 1 0.01 57.42 KETONURIA | 1 0.01 57.43 KIDNEY INFECTION | 1 0.01 57.44 KINESITHERAPY | 1 0.01 57.45 KLEBSIELLA BACTERAEMIA | 1 0.01 57.46 KNEE ARTHROPLASTY | 5 0.05 57.51 KNEE OPERATION | 1 0.01 57.52 KOEBNER PHENOMENON | 1 0.01 57.53 LABILE HYPERTENSION | 1 0.01 57.54 LABORATORY TEST ABNORMAL | 5 0.05 57.59 LACRIMATION INCREASED | 2 0.02 57.61 LACTATION DISORDER | 1 0.01 57.62 LACTIC ACIDOSIS | 8 0.08 57.70 LACUNAR INFARCTION | 1 0.01 57.71 LAGOPHTHALMOS | 1 0.01 57.72 LAPAROSCOPY | 1 0.01 57.73 LAPAROTOMY | 3 0.03 57.76 LARGE CELL CARCINOMA OF THE RESPIRATO.. | 1 0.01 57.77 LARGE INTESTINAL ULCER | 1 0.01 57.78 LARGE INTESTINE PERFORATION | 3 0.03 57.81 LARYNGEAL HAEMORRHAGE | 1 0.01 57.82 LARYNGEAL OEDEMA | 2 0.02 57.84 LARYNGITIS | 1 0.01 57.85 LARYNGOSPASM | 2 0.02 57.87 LEARNING DISORDER | 1 0.01 57.88 LEFT VENTRICULAR DYSFUNCTION | 1 0.01 57.89 LEFT VENTRICULAR FAILURE | 2 0.02 57.91 LEFT VENTRICULAR HYPERTROPHY | 1 0.01 57.92 LETHARGY | 10 0.10 58.02 LEUKAEMIA RECURRENT | 1 0.01 58.03 LEUKOCYTOCLASTIC VASCULITIS | 3 0.03 58.06 LEUKOCYTOSIS | 7 0.07 58.13 LEUKOPENIA | 12 0.12 58.25 LIBIDO DECREASED | 1 0.01 58.26 LIBIDO INCREASED | 1 0.01 58.27 LICHEN PLANUS | 1 0.01 58.28 LICHENIFICATION | 1 0.01 58.29 LIFE EXPECTANCY SHORTENED | 2 0.02 58.31 LIFE SUPPORT | 1 0.01 58.32 LIGAMENT DISORDER | 1 0.01 58.33 LIGAMENT SPRAIN | 2 0.02 58.35 LIMB INJURY | 2 0.02 58.37 LIP BLISTER | 1 0.01 58.38 LIP DRY | 1 0.01 58.39 LIP EXFOLIATION | 1 0.01 58.40 LIP OEDEMA | 2 0.02 58.42 LIP PAIN | 1 0.01 58.43 LIP SWELLING | 5 0.05 58.48 LIP ULCERATION | 2 0.02 58.50 LIPASE INCREASED | 3 0.03 58.53 LIPIDS INCREASED | 2 0.02 58.55 LIPOATROPHY | 1 0.01 58.56 LIPODYSTROPHY ACQUIRED | 1 0.01 58.57 LIPOHYPERTROPHY | 1 0.01 58.58 LIPOMA | 2 0.02 58.60 LISTERIOSIS | 1 0.01 58.61 LITHOTRIPSY | 2 0.02 58.63 LIVEDO RETICULARIS | 1 0.01 58.64 LIVER DISORDER | 19 0.19 58.83 LIVER FUNCTION TEST ABNORMAL | 10 0.10 58.93 LIVING IN RESIDENTIAL INSTITUTION | 1 0.01 58.94 LOBAR PNEUMONIA | 3 0.03 58.97 LOCAL SWELLING | 2 0.02 58.99 LOCALISED INFECTION | 2 0.02 59.01 LOCALISED INTRAABDOMINAL FLUID COLLEC.. | 1 0.01 59.02 LOOSE BODY IN JOINT | 1 0.01 59.03 LOOSE TOOTH | 1 0.01 59.04 LOSS OF CONSCIOUSNESS | 50 0.50 59.54 LOSS OF CONTROL OF LEGS | 1 0.01 59.55 LOSS OF LIBIDO | 1 0.01 59.56 LOW CARDIAC OUTPUT SYNDROME | 1 0.01 59.57 LOW DENSITY LIPOPROTEIN | 1 0.01 59.58 LOWER LIMB FRACTURE | 1 0.01 59.59 LOWER RESPIRATORY TRACT INFECTION | 6 0.06 59.65 LUNG ADENOCARCINOMA | 2 0.02 59.67 LUNG CANCER METASTATIC | 1 0.01 59.68 LUNG CONSOLIDATION | 2 0.02 59.70 LUNG DISORDER | 8 0.08 59.78 LUNG INFECTION | 5 0.05 59.83 LUNG INFECTION PSEUDOMONAL | 3 0.03 59.86 LUNG INFILTRATION | 9 0.09 59.95 LUNG NEOPLASM | 1 0.01 59.96 LUNG NEOPLASM MALIGNANT | 5 0.05 60.01 LUPUS-LIKE SYNDROME | 3 0.03 60.04 LYMPH NODE CALCIFICATION | 1 0.01 60.05 LYMPH NODE TUBERCULOSIS | 1 0.01 60.06 LYMPHADENITIS | 2 0.02 60.08 LYMPHADENOPATHY | 11 0.11 60.19 LYMPHADENOPATHY MEDIASTINAL | 1 0.01 60.20 LYMPHOCELE | 2 0.02 60.22 LYMPHOCYTE COUNT DECREASED | 4 0.04 60.26 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 60.27 LYMPHOEDEMA | 1 0.01 60.28 LYMPHOMA | 3 0.03 60.31 LYMPHOPENIA | 1 0.01 60.32 LYMPHOPROLIFERATIVE DISORDER | 2 0.02 60.34 MACROCYTOSIS | 1 0.01 60.35 MACULAR DEGENERATION | 4 0.04 60.39 MACULOPATHY | 2 0.02 60.41 MADAROSIS | 1 0.01 60.42 MALABSORPTION | 1 0.01 60.43 MALAISE | 70 0.70 61.13 MALARIA | 1 0.01 61.14 MALIGNANT BREAST LUMP REMOVAL | 2 0.02 61.16 MALIGNANT FIBROUS HISTIOCYTOMA | 1 0.01 61.17 MALIGNANT NEOPLASM PROGRESSION | 18 0.18 61.35 MALIGNANT PLEURAL EFFUSION | 1 0.01 61.36 MALLORY-WEISS SYNDROME | 2 0.02 61.38 MALNUTRITION | 6 0.06 61.44 MAMMOGRAM ABNORMAL | 1 0.01 61.45 MANIA | 5 0.05 61.50 MASS | 1 0.01 61.51 MASS EXCISION | 1 0.01 61.52 MASTICATION DISORDER | 1 0.01 61.53 MASTITIS | 1 0.01 61.54 MEAN CELL HAEMOGLOBIN CONCENTRATION D.. | 1 0.01 61.55 MEAN PLATELET VOLUME INCREASED | 1 0.01 61.56 MECHANICAL ILEUS | 2 0.02 61.58 MECONIUM IN AMNIOTIC FLUID | 1 0.01 61.59 MEDIASTINITIS | 1 0.01 61.60 MEDICAL DEVICE COMPLICATION | 2 0.02 61.62 MEDICATION ERROR | 14 0.14 61.76 MEDICATION TAMPERING | 1 0.01 61.77 MEGAKARYOCYTES ABNORMAL | 1 0.01 61.78 MELAENA | 5 0.05 61.83 MELANOCYTIC NAEVUS | 2 0.02 61.85 MEMORY IMPAIRMENT | 16 0.16 62.01 MENINGEAL DISORDER | 1 0.01 62.02 MENINGITIS | 1 0.01 62.03 MENINGITIS LISTERIA | 1 0.01 62.04 MENINGITIS VIRAL | 1 0.01 62.05 MENOMETRORRHAGIA | 2 0.02 62.07 MENORRHAGIA | 8 0.08 62.15 MENSTRUAL DISORDER | 1 0.01 62.16 MENSTRUATION DELAYED | 1 0.01 62.17 MENSTRUATION IRREGULAR | 1 0.01 62.18 MENTAL DISORDER | 5 0.05 62.23 MENTAL RETARDATION SEVERITY UNSPECIFIED | 1 0.01 62.24 MENTAL STATUS CHANGES | 10 0.10 62.34 MESENTERIC VEIN THROMBOSIS | 2 0.02 62.36 METABOLIC ACIDOSIS | 8 0.08 62.44 METABOLIC DISORDER | 4 0.04 62.48 METABOLIC ENCEPHALOPATHY | 1 0.01 62.49 METASTASES TO BONE | 2 0.02 62.51 METASTASES TO CENTRAL NERVOUS SYSTEM | 5 0.05 62.56 METASTASES TO HEART | 1 0.01 62.57 METASTASES TO LIVER | 2 0.02 62.59 METASTASES TO LUNG | 2 0.02 62.61 METASTASES TO LYMPH NODES | 2 0.02 62.63 METASTASES TO PERITONEUM | 1 0.01 62.64 METASTASES TO SKIN | 1 0.01 62.65 METASTASIS | 3 0.03 62.68 METASTATIC RENAL CELL CARCINOMA | 1 0.01 62.69 METASTATIC SQUAMOUS CELL CARCINOMA | 2 0.02 62.71 METHICILLIN-RESISTANT STAPHYLOCOCCAL .. | 1 0.01 62.72 METRORRHAGIA | 5 0.05 62.77 MICROALBUMINURIA | 1 0.01 62.78 MICROGNATHIA | 1 0.01 62.79 MICTURITION URGENCY | 10 0.10 62.89 MIDDLE INSOMNIA | 2 0.02 62.91 MIGRAINE | 2 0.02 62.93 MILK ALLERGY | 1 0.01 62.94 MILLER FISHER SYNDROME | 1 0.01 62.95 MIOSIS | 2 0.02 62.97 MITRAL VALVE DISEASE | 2 0.02 62.99 MITRAL VALVE HYPOPLASIA | 1 0.01 63.00 MITRAL VALVE INCOMPETENCE | 3 0.03 63.03 MITRAL VALVE PROLAPSE | 1 0.01 63.04 MIXED CONNECTIVE TISSUE DISEASE | 1 0.01 63.05 MIXED HEPATOCELLULAR-CHOLESTATIC INJURY | 1 0.01 63.06 MOBILITY DECREASED | 11 0.11 63.17 MONOCYTE COUNT DECREASED | 2 0.02 63.19 MONOCYTE COUNT INCREASED | 2 0.02 63.21 MONOPLEGIA | 2 0.02 63.23 MOOD ALTERED | 1 0.01 63.24 MOOD SWINGS | 2 0.02 63.26 MOTOR DYSFUNCTION | 2 0.02 63.28 MOUTH HAEMORRHAGE | 3 0.03 63.31 MOUTH ULCERATION | 6 0.06 63.37 MOVEMENT DISORDER | 3 0.03 63.40 MUCORMYCOSIS | 1 0.01 63.41 MUCOSAL INFLAMMATION | 12 0.12 63.53 MUCOUS MEMBRANE DISORDER | 1 0.01 63.54 MUCOUS STOOLS | 1 0.01 63.55 MULTI-ORGAN DISORDER | 1 0.01 63.56 MULTI-ORGAN FAILURE | 11 0.11 63.67 MULTIPLE ALLERGIES | 1 0.01 63.68 MULTIPLE DRUG OVERDOSE ACCIDENTAL | 1 0.01 63.69 MULTIPLE DRUG OVERDOSE INTENTIONAL | 2 0.02 63.71 MULTIPLE MYELOMA | 3 0.03 63.74 MULTIPLE SCLEROSIS | 13 0.13 63.87 MUSCLE ATROPHY | 2 0.02 63.89 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 63.90 MUSCLE CONTRACTURE | 1 0.01 63.91 MUSCLE DISORDER | 1 0.01 63.92 MUSCLE INJURY | 1 0.01 63.93 MUSCLE RIGIDITY | 2 0.02 63.95 MUSCLE SPASMS | 23 0.23 64.18 MUSCLE SPASTICITY | 2 0.02 64.20 MUSCLE TIGHTNESS | 4 0.04 64.24 MUSCLE TWITCHING | 3 0.03 64.27 MUSCULAR WEAKNESS | 20 0.20 64.47 MUSCULOSKELETAL CHEST PAIN | 4 0.04 64.51 MUSCULOSKELETAL PAIN | 9 0.09 64.60 MUSCULOSKELETAL STIFFNESS | 8 0.08 64.68 MUTISM | 2 0.02 64.70 MYALGIA | 24 0.24 64.94 MYASTHENIA GRAVIS | 1 0.01 64.95 MYASTHENIA GRAVIS CRISIS | 1 0.01 64.96 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 64.97 MYCOSIS FUNGOIDES | 1 0.01 64.98 MYDRIASIS | 2 0.02 65.00 MYELOBLAST COUNT INCREASED | 1 0.01 65.01 MYELODYSPLASTIC SYNDROME | 4 0.04 65.05 MYELOID MATURATION ARREST | 1 0.01 65.06 MYOCARDIAL INFARCTION | 45 0.45 65.51 MYOCARDIAL ISCHAEMIA | 5 0.05 65.56 MYOCARDITIS | 2 0.02 65.58 MYOCLONUS | 6 0.06 65.64 MYOFASCITIS | 1 0.01 65.65 MYOGLOBIN BLOOD INCREASED | 1 0.01 65.66 MYOGLOBINURIA | 1 0.01 65.67 MYOPATHY | 5 0.05 65.72 MYOSITIS | 2 0.02 65.74 NAIL DISORDER | 1 0.01 65.75 NASAL CONGESTION | 7 0.07 65.82 NASAL DISORDER | 2 0.02 65.84 NASAL OPERATION | 1 0.01 65.85 NASAL POLYPS | 1 0.01 65.86 NASAL SEPTUM DEVIATION | 1 0.01 65.87 NASOPHARYNGITIS | 9 0.09 65.96 NAUSEA | 94 0.94 66.90 NECK INJURY | 1 0.01 66.91 NECK PAIN | 6 0.06 66.97 NECROSIS | 1 0.01 66.98 NEONATAL ASPHYXIA | 3 0.03 67.01 NEONATAL DISORDER | 1 0.01 67.02 NEONATAL INFECTION | 2 0.02 67.04 NEONATAL RESPIRATORY DISTRESS SYNDROME | 1 0.01 67.05 NEONATAL TACHYPNOEA | 1 0.01 67.06 NEOPLASM | 3 0.03 67.09 NEOPLASM MALIGNANT | 5 0.05 67.14 NEOPLASM RECURRENCE | 1 0.01 67.15 NEOVASCULARISATION | 1 0.01 67.16 NEPHRITIS INTERSTITIAL | 2 0.02 67.18 NEPHROGENIC DIABETES INSIPIDUS | 1 0.01 67.19 NEPHROGENIC SYSTEMIC FIBROSIS | 5 0.05 67.24 NEPHROLITHIASIS | 6 0.06 67.30 NEPHROPATHY | 1 0.01 67.31 NEPHROPATHY TOXIC | 5 0.05 67.36 NEPHROSCLEROSIS | 2 0.02 67.38 NEPHROTIC SYNDROME | 2 0.02 67.40 NERVE COMPRESSION | 2 0.02 67.42 NERVE CONDUCTION STUDIES ABNORMAL | 1 0.01 67.43 NERVE ROOT COMPRESSION | 1 0.01 67.44 NERVOUS SYSTEM DISORDER | 12 0.12 67.56 NERVOUS SYSTEM SURGERY | 1 0.01 67.57 NERVOUSNESS | 12 0.12 67.69 NEURAL TUBE DEFECT | 1 0.01 67.70 NEURALGIA | 1 0.01 67.71 NEURITIS | 1 0.01 67.72 NEUROGENIC BLADDER | 2 0.02 67.74 NEUROLEPTIC MALIGNANT SYNDROME | 7 0.07 67.81 NEUROLOGICAL SYMPTOM | 1 0.01 67.82 NEUROPATHY | 12 0.12 67.94 NEUROPATHY PERIPHERAL | 4 0.04 67.98 NEUROSIS | 2 0.02 68.00 NEUTROPENIA | 33 0.33 68.33 NEUTROPENIC SEPSIS | 3 0.03 68.36 NEUTROPHIL COUNT DECREASED | 15 0.15 68.51 NEUTROPHIL COUNT INCREASED | 5 0.05 68.56 NEUTROPHIL MORPHOLOGY ABNORMAL | 1 0.01 68.57 NEUTROPHILIA | 1 0.01 68.58 NIGHT BLINDNESS | 2 0.02 68.60 NIGHT SWEATS | 2 0.02 68.62 NIGHTMARE | 4 0.04 68.66 NIPPLE PAIN | 1 0.01 68.67 NO ADVERSE DRUG REACTION | 4 0.04 68.71 NO ADVERSE REACTION | 2 0.02 68.73 NO THERAPEUTIC RESPONSE | 7 0.07 68.80 NOCTURIA | 1 0.01 68.81 NODAL ARRHYTHMIA | 1 0.01 68.82 NODULAR REGENERATIVE HYPERPLASIA | 1 0.01 68.83 NODULE | 1 0.01 68.84 NODULE ON EXTREMITY | 1 0.01 68.85 NON-CARDIAC CHEST PAIN | 2 0.02 68.87 NON-CARDIOGENIC PULMONARY OEDEMA | 1 0.01 68.88 NON-HODGKIN'S LYMPHOMA | 1 0.01 68.89 NON-HODGKIN'S LYMPHOMA RECURRENT | 1 0.01 68.90 NON-NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 68.91 NON-SMALL CELL LUNG CANCER | 1 0.01 68.92 NORMAL NEWBORN | 4 0.04 68.96 NORMOCHROMIC NORMOCYTIC ANAEMIA | 3 0.03 68.99 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 69.01 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 3 0.03 69.04 NUTRITIONAL CONDITION ABNORMAL | 1 0.01 69.05 NYSTAGMUS | 3 0.03 69.08 OBESITY | 1 0.01 69.09 OBLITERATIVE BRONCHIOLITIS | 2 0.02 69.11 OBSESSIVE THOUGHTS | 1 0.01 69.12 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 69.15 OBSTRUCTION | 2 0.02 69.17 OBSTRUCTIVE AIRWAYS DISORDER | 4 0.04 69.21 OCCULT BLOOD POSITIVE | 2 0.02 69.23 OCULAR DISCOMFORT | 1 0.01 69.24 OCULAR HYPERAEMIA | 4 0.04 69.28 OCULAR ICTERUS | 1 0.01 69.29 OCULOGYRIC CRISIS | 1 0.01 69.30 OCULOMUCOCUTANEOUS SYNDROME | 3 0.03 69.33 ODONTOGENIC CYST | 1 0.01 69.34 OEDEMA | 18 0.18 69.52 OEDEMA GENITAL | 1 0.01 69.53 OEDEMA MOUTH | 8 0.08 69.61 OEDEMA MUCOSAL | 1 0.01 69.62 OEDEMA PERIPHERAL | 35 0.35 69.97 OESOPHAGEAL PAIN | 1 0.01 69.98 OESOPHAGEAL SPASM | 1 0.01 69.99 OESOPHAGEAL ULCER | 5 0.05 70.04 OESOPHAGITIS | 8 0.08 70.12 OFF LABEL USE | 3 0.03 70.15 OLIGURIA | 5 0.05 70.20 ONCHOCERCIASIS | 1 0.01 70.21 ONYCHOPHAGIA | 1 0.01 70.22 OOPHORECTOMY | 1 0.01 70.23 OPERATIVE HAEMORRHAGE | 2 0.02 70.25 OPHTHALMOPLEGIA | 1 0.01 70.26 OPTIC ATROPHY | 1 0.01 70.27 OPTIC ISCHAEMIC NEUROPATHY | 2 0.02 70.29 OPTIC NERVE DISORDER | 2 0.02 70.31 OPTIC NERVE INJURY | 1 0.01 70.32 OPTIC NEURITIS | 3 0.03 70.35 OPTIC NEUROPATHY | 2 0.02 70.37 ORAL CANDIDIASIS | 4 0.04 70.41 ORAL CAVITY FISTULA | 1 0.01 70.42 ORAL DISCOMFORT | 8 0.08 70.50 ORAL DISORDER | 2 0.02 70.52 ORAL DYSAESTHESIA | 1 0.01 70.53 ORAL FUNGAL INFECTION | 1 0.01 70.54 ORAL HERPES | 2 0.02 70.56 ORAL INFECTION | 1 0.01 70.57 ORAL INTAKE REDUCED | 13 0.13 70.70 ORAL MUCOSAL BLISTERING | 1 0.01 70.71 ORAL MUCOSAL ERUPTION | 1 0.01 70.72 ORAL MUCOSAL EXFOLIATION | 1 0.01 70.73 ORAL PAIN | 6 0.06 70.79 ORAL PRURITUS | 3 0.03 70.82 ORAL SURGERY | 1 0.01 70.83 ORGAN FAILURE | 2 0.02 70.85 OROPHARYNGEAL CANDIDIASIS | 1 0.01 70.86 ORTHOPNOEA | 1 0.01 70.87 ORTHOSTATIC HYPOTENSION | 1 0.01 70.88 OSTEITIS | 1 0.01 70.89 OSTEITIS DEFORMANS | 1 0.01 70.90 OSTEOARTHRITIS | 5 0.05 70.95 OSTEOCHONDROSIS | 1 0.01 70.96 OSTEOMALACIA | 2 0.02 70.98 OSTEOMYELITIS | 12 0.12 71.10 OSTEOMYELITIS CHRONIC | 2 0.02 71.12 OSTEONECROSIS | 39 0.39 71.51 OSTEOPENIA | 2 0.02 71.53 OSTEOPOROSIS | 4 0.04 71.57 OSTEOTOMY | 1 0.01 71.58 OTITIS MEDIA CHRONIC | 1 0.01 71.59 OVARIAN CANCER | 1 0.01 71.60 OVARIAN CANCER RECURRENT | 1 0.01 71.61 OVARIAN CYST | 4 0.04 71.65 OVARIAN DISORDER | 1 0.01 71.66 OVERDOSE | 32 0.32 71.98 OXYGEN SATURATION ABNORMAL | 1 0.01 71.99 OXYGEN SATURATION DECREASED | 15 0.15 72.14 PAIN | 58 0.58 72.72 PAIN IN EXTREMITY | 34 0.34 73.06 PAIN IN JAW | 5 0.05 73.11 PAIN OF SKIN | 1 0.01 73.12 PALLOR | 2 0.02 73.14 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 4 0.04 73.18 PALPITATIONS | 29 0.29 73.47 PANCREATIC CARCINOMA | 3 0.03 73.50 PANCREATIC CARCINOMA METASTATIC | 1 0.01 73.51 PANCREATIC ENZYMES INCREASED | 1 0.01 73.52 PANCREATIC NECROSIS | 1 0.01 73.53 PANCREATIC PSEUDOCYST | 1 0.01 73.54 PANCREATITIS | 17 0.17 73.71 PANCREATITIS ACUTE | 7 0.07 73.78 PANCREATITIS CHRONIC | 1 0.01 73.79 PANCREATITIS HAEMORRHAGIC | 1 0.01 73.80 PANCREATITIS NECROTISING | 1 0.01 73.81 PANCYTOPENIA | 29 0.29 74.10 PANIC ATTACK | 8 0.08 74.18 PANIC REACTION | 3 0.03 74.21 PAPILLARY THYROID CANCER | 1 0.01 74.22 PAPILLOEDEMA | 2 0.02 74.24 PARADOXICAL DRUG REACTION | 1 0.01 74.25 PARAESTHESIA | 21 0.21 74.46 PARAESTHESIA ORAL | 2 0.02 74.48 PARALYSIS | 4 0.04 74.52 PARALYSIS FLACCID | 1 0.01 74.53 PARANOIA | 6 0.06 74.59 PARAPLEGIA | 2 0.02 74.61 PARKINSON'S DISEASE | 2 0.02 74.63 PARKINSONIAN REST TREMOR | 1 0.01 74.64 PARKINSONISM | 2 0.02 74.66 PAROSMIA | 1 0.01 74.67 PATELLA FRACTURE | 1 0.01 74.68 PATELLOFEMORAL PAIN SYNDROME | 1 0.01 74.69 PATENT DUCTUS ARTERIOSUS | 1 0.01 74.70 PATHOLOGICAL FRACTURE | 4 0.04 74.74 PATHOLOGICAL GAMBLING | 1 0.01 74.75 PCO2 DECREASED | 1 0.01 74.76 PELVIC FRACTURE | 1 0.01 74.77 PELVIC INFLAMMATORY DISEASE | 1 0.01 74.78 PELVIC PAIN | 2 0.02 74.80 PELVIC VENOUS THROMBOSIS | 2 0.02 74.82 PEMPHIGOID | 3 0.03 74.85 PEPTIC ULCER | 1 0.01 74.86 PERFORMANCE STATUS DECREASED | 1 0.01 74.87 PERICARDIAL DISEASE | 1 0.01 74.88 PERICARDIAL DRAINAGE | 1 0.01 74.89 PERICARDIAL EFFUSION | 12 0.12 75.01 PERICARDITIS | 1 0.01 75.02 PERICARDITIS CONSTRICTIVE | 1 0.01 75.03 PERICARDITIS TUBERCULOUS | 1 0.01 75.04 PERIODONTITIS | 1 0.01 75.05 PERIPHERAL ARTERY ANEURYSM | 1 0.01 75.06 PERIPHERAL COLDNESS | 3 0.03 75.09 PERIPHERAL ISCHAEMIA | 1 0.01 75.10 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 75.11 PERIPHERAL VASCULAR DISORDER | 2 0.02 75.13 PERITONEAL HAEMORRHAGE | 2 0.02 75.15 PERITONEAL PERFORATION | 2 0.02 75.17 PERITONITIS | 1 0.01 75.18 PERITONITIS BACTERIAL | 3 0.03 75.21 PERONEAL NERVE PALSY | 1 0.01 75.22 PERSONALITY CHANGE | 4 0.04 75.26 PETECHIAE | 6 0.06 75.32 PETIT MAL EPILEPSY | 3 0.03 75.35 PHARMACEUTICAL PRODUCT COMPLAINT | 51 0.51 75.86 PHARYNGEAL ERYTHEMA | 1 0.01 75.87 PHARYNGEAL FISTULA | 1 0.01 75.88 PHARYNGEAL HAEMORRHAGE | 3 0.03 75.91 PHARYNGEAL OEDEMA | 3 0.03 75.94 PHARYNGEAL ULCERATION | 2 0.02 75.96 PHARYNGITIS | 4 0.04 76.00 PHARYNGITIS STREPTOCOCCAL | 2 0.02 76.02 PHARYNGOLARYNGEAL PAIN | 8 0.08 76.10 PHLEBITIS | 6 0.06 76.16 PHLEBITIS SUPERFICIAL | 1 0.01 76.17 PHOTOPHOBIA | 4 0.04 76.21 PHYSICAL ASSAULT | 2 0.02 76.23 PHYSICAL DISABILITY | 1 0.01 76.24 PIGMENTATION DISORDER | 2 0.02 76.26 PITYRIASIS | 1 0.01 76.27 PLACENTAL DISORDER | 2 0.02 76.29 PLACENTAL INFARCTION | 1 0.01 76.30 PLASTIC SURGERY | 2 0.02 76.32 PLATELET COUNT DECREASED | 32 0.32 76.64 PLATELET COUNT INCREASED | 2 0.02 76.66 PLATELET DISORDER | 1 0.01 76.67 PLEURAL DISORDER | 1 0.01 76.68 PLEURAL EFFUSION | 27 0.27 76.95 PLEURISY | 3 0.03 76.98 PLEURITIC PAIN | 2 0.02 77.00 PNEUMATOSIS INTESTINALIS | 1 0.01 77.01 PNEUMOCOCCAL INFECTION | 1 0.01 77.02 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 77.06 PNEUMONIA | 59 0.59 77.65 PNEUMONIA ASPIRATION | 7 0.07 77.72 PNEUMONIA BACTERIAL | 3 0.03 77.75 PNEUMONIA FUNGAL | 1 0.01 77.76 PNEUMONIA PARAINFLUENZAE VIRAL | 3 0.03 77.79 PNEUMONIA PNEUMOCOCCAL | 1 0.01 77.80 PNEUMONIA STAPHYLOCOCCAL | 2 0.02 77.82 PNEUMONIA STREPTOCOCCAL | 1 0.01 77.83 PNEUMONIA VIRAL | 1 0.01 77.84 PNEUMONITIS | 8 0.08 77.92 PNEUMOTHORAX | 3 0.03 77.95 PO2 ABNORMAL | 1 0.01 77.96 PO2 DECREASED | 1 0.01 77.97 POISONING | 2 0.02 77.99 POLLAKIURIA | 16 0.16 78.15 POLYARTHRITIS | 2 0.02 78.17 POLYCYTHAEMIA | 1 0.01 78.18 POLYDIPSIA | 1 0.01 78.19 POLYHYDRAMNIOS | 2 0.02 78.21 POLYMENORRHOEA | 1 0.01 78.22 POLYMYOSITIS | 1 0.01 78.23 POLYNEUROPATHY | 5 0.05 78.28 POLYP | 1 0.01 78.29 POLYP COLORECTAL | 1 0.01 78.30 POLYURIA | 3 0.03 78.33 POOR QUALITY DRUG ADMINISTERED | 5 0.05 78.38 POOR QUALITY SLEEP | 4 0.04 78.42 PORPHYRIA | 1 0.01 78.43 PORTAL VEIN THROMBOSIS | 1 0.01 78.44 POST PROCEDURAL COMPLICATION | 7 0.07 78.51 POST PROCEDURAL HAEMATOMA | 3 0.03 78.54 POST PROCEDURAL HAEMORRHAGE | 2 0.02 78.56 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 78.57 POSTNASAL DRIP | 1 0.01 78.58 POSTPARTUM DISORDER | 1 0.01 78.59 POSTURE ABNORMAL | 4 0.04 78.63 POSTURING | 1 0.01 78.64 POUCHITIS | 3 0.03 78.67 PRE-ECLAMPSIA | 2 0.02 78.69 PREGNANCY | 10 0.10 78.79 PREGNANCY INDUCED HYPERTENSION | 1 0.01 78.80 PREGNANCY ON ORAL CONTRACEPTIVE | 1 0.01 78.81 PREGNANCY WITH CONTRACEPTIVE PATCH | 1 0.01 78.82 PREMATURE BABY | 3 0.03 78.85 PREMATURE LABOUR | 3 0.03 78.88 PRESBYOPIA | 1 0.01 78.89 PRESYNCOPE | 1 0.01 78.90 PRIMARY SEQUESTRUM | 1 0.01 78.91 PROCEDURAL COMPLICATION | 1 0.01 78.92 PROCEDURAL PAIN | 1 0.01 78.93 PROCTITIS | 1 0.01 78.94 PROCTITIS ULCERATIVE | 2 0.02 78.96 PRODUCTIVE COUGH | 10 0.10 79.06 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 3 0.03 79.09 PROLONGED LABOUR | 1 0.01 79.10 PROSTATE CANCER | 5 0.05 79.15 PROSTATE CANCER METASTATIC | 1 0.01 79.16 PROSTATE EXAMINATION ABNORMAL | 1 0.01 79.17 PROSTATE TENDERNESS | 1 0.01 79.18 PROSTATIC SPECIFIC ANTIGEN INCREASED | 3 0.03 79.21 PROSTATITIS | 1 0.01 79.22 PROSTRATION | 1 0.01 79.23 PROTEIN TOTAL DECREASED | 2 0.02 79.25 PROTEIN URINE PRESENT | 1 0.01 79.26 PROTEINURIA | 3 0.03 79.29 PROTHROMBIN LEVEL DECREASED | 1 0.01 79.30 PROTHROMBIN TIME PROLONGED | 4 0.04 79.34 PROTHROMBIN TIME SHORTENED | 2 0.02 79.36 PRURITUS | 21 0.21 79.57 PRURITUS GENERALISED | 1 0.01 79.58 PSEUDOMONAS INFECTION | 4 0.04 79.62 PSEUDOPOLYP | 2 0.02 79.64 PSORIASIS | 3 0.03 79.67 PSYCHIATRIC SYMPTOM | 3 0.03 79.70 PSYCHOMOTOR HYPERACTIVITY | 4 0.04 79.74 PSYCHOMOTOR SKILLS IMPAIRED | 3 0.03 79.77 PSYCHOTIC DISORDER | 13 0.13 79.90 PUBIC RAMI FRACTURE | 1 0.01 79.91 PULMONARY ALVEOLAR HAEMORRHAGE | 1 0.01 79.92 PULMONARY ARTERIAL WEDGE PRESSURE DEC.. | 1 0.01 79.93 PULMONARY CONGESTION | 9 0.09 80.02 PULMONARY EMBOLISM | 25 0.25 80.27 PULMONARY FIBROSIS | 6 0.06 80.33 PULMONARY HAEMORRHAGE | 4 0.04 80.37 PULMONARY HYPERTENSION | 9 0.09 80.46 PULMONARY MALFORMATION | 1 0.01 80.47 PULMONARY MYCOSIS | 2 0.02 80.49 PULMONARY OEDEMA | 16 0.16 80.65 PULMONARY THROMBOSIS | 1 0.01 80.66 PULMONARY TUBERCULOSIS | 1 0.01 80.67 PULSE ABSENT | 2 0.02 80.69 PUNCTATE KERATITIS | 1 0.01 80.70 PUPILLARY REFLEX IMPAIRED | 1 0.01 80.71 PURPURA | 3 0.03 80.74 PURULENCE | 2 0.02 80.76 PURULENT DISCHARGE | 4 0.04 80.80 PUSTULAR PSORIASIS | 3 0.03 80.83 PYELECTASIA | 1 0.01 80.84 PYELOCALIECTASIS | 1 0.01 80.85 PYELONEPHRITIS | 3 0.03 80.88 PYELONEPHRITIS ACUTE | 1 0.01 80.89 PYODERMA | 1 0.01 80.90 PYRAMIDAL TRACT SYNDROME | 1 0.01 80.91 PYREXIA | 97 0.97 81.88 QUADRIPARESIS | 1 0.01 81.89 RADIATION OESOPHAGITIS | 1 0.01 81.90 RADIATION PNEUMONITIS | 3 0.03 81.93 RADIATION SKIN INJURY | 1 0.01 81.94 RADICULOPATHY | 1 0.01 81.95 RADIOTHERAPY | 1 0.01 81.96 RADIUS FRACTURE | 2 0.02 81.98 RALES | 3 0.03 82.01 RASH | 34 0.34 82.35 RASH ERYTHEMATOUS | 5 0.05 82.40 RASH GENERALISED | 7 0.07 82.47 RASH MACULO-PAPULAR | 8 0.08 82.55 RASH PAPULAR | 2 0.02 82.57 RASH PRURITIC | 2 0.02 82.59 RASH PUSTULAR | 6 0.06 82.65 RASH VESICULAR | 2 0.02 82.67 RAYNAUD'S PHENOMENON | 1 0.01 82.68 REACTION TO DRUG EXCIPIENTS | 2 0.02 82.70 RECTAL CANCER | 1 0.01 82.71 RECTAL HAEMORRHAGE | 13 0.13 82.84 RECTAL SPASM | 1 0.01 82.85 RECTAL TENESMUS | 1 0.01 82.86 RECURRENT CANCER | 1 0.01 82.87 RED BLOOD CELL COUNT DECREASED | 10 0.10 82.97 RED BLOOD CELL MORPHOLOGY | 1 0.01 82.98 RED BLOOD CELL SEDIMENTATION RATE INC.. | 2 0.02 83.00 RED CELL DISTRIBUTION WIDTH INCREASED | 1 0.01 83.01 REFRACTORY ANAEMIA | 1 0.01 83.02 REFUSAL OF TREATMENT BY PATIENT | 2 0.02 83.04 REGURGITATION | 1 0.01 83.05 REMOVAL OF AMBULATORY PERITONEAL CATH.. | 1 0.01 83.06 RENAL ARTERY STENT PLACEMENT | 1 0.01 83.07 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 6 0.06 83.13 RENAL COLIC | 1 0.01 83.14 RENAL CYST | 3 0.03 83.17 RENAL DISORDER | 10 0.10 83.27 RENAL DYSPLASIA | 1 0.01 83.28 RENAL FAILURE | 43 0.43 83.71 RENAL FAILURE ACUTE | 44 0.44 84.15 RENAL FAILURE CHRONIC | 4 0.04 84.19 RENAL HAEMORRHAGE | 1 0.01 84.20 RENAL HYPERTENSION | 1 0.01 84.21 RENAL IMPAIRMENT | 14 0.14 84.35 RENAL INJURY | 1 0.01 84.36 RENAL NEOPLASM | 1 0.01 84.37 RENAL PAIN | 3 0.03 84.40 RENAL PAPILLARY NECROSIS | 1 0.01 84.41 RENAL STONE REMOVAL | 1 0.01 84.42 RENAL TRANSPLANT | 2 0.02 84.44 RENAL TUBULAR ACIDOSIS | 1 0.01 84.45 RENAL TUBULAR DISORDER | 1 0.01 84.46 RENAL TUBULAR NECROSIS | 3 0.03 84.49 RESORPTION BONE INCREASED | 1 0.01 84.50 RESPIRATION ABNORMAL | 3 0.03 84.53 RESPIRATORY ACIDOSIS | 4 0.04 84.57 RESPIRATORY ARREST | 4 0.04 84.61 RESPIRATORY DEPRESSION | 3 0.03 84.64 RESPIRATORY DISORDER | 3 0.03 84.67 RESPIRATORY DISTRESS | 5 0.05 84.72 RESPIRATORY FAILURE | 27 0.27 84.99 RESPIRATORY RATE INCREASED | 1 0.01 85.00 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOL.. | 1 0.01 85.01 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 85.02 RESPIRATORY THERAPY | 1 0.01 85.03 RESPIRATORY TRACT CONGESTION | 1 0.01 85.04 RESPIRATORY TRACT INFECTION | 2 0.02 85.06 RESPIRATORY TRACT IRRITATION | 1 0.01 85.07 RESTLESS LEGS SYNDROME | 6 0.06 85.13 RESTLESSNESS | 13 0.13 85.26 RESTRICTIVE CARDIOMYOPATHY | 1 0.01 85.27 RESUSCITATION | 3 0.03 85.30 RETAINED PLACENTA OR MEMBRANES | 1 0.01 85.31 RETCHING | 2 0.02 85.33 RETICULOCYTE COUNT INCREASED | 1 0.01 85.34 RETINAL DETACHMENT | 3 0.03 85.37 RETINAL HAEMORRHAGE | 2 0.02 85.39 RETINAL OEDEMA | 1 0.01 85.40 RETINAL VASCULAR DISORDER | 1 0.01 85.41 RETINOPATHY | 1 0.01 85.42 RETROPERITONEAL FIBROSIS | 1 0.01 85.43 RETROPERITONEAL HAEMATOMA | 1 0.01 85.44 RETROPERITONEAL LYMPHADENOPATHY | 1 0.01 85.45 RETROPERITONEAL NEOPLASM | 2 0.02 85.47 RHABDOMYOLYSIS | 15 0.15 85.62 RHEUMATOID ARTHRITIS | 8 0.08 85.70 RHEUMATOID LUNG | 1 0.01 85.71 RHEUMATOID VASCULITIS | 1 0.01 85.72 RHINITIS | 2 0.02 85.74 RHINITIS ALLERGIC | 1 0.01 85.75 RHINOPLASTY | 1 0.01 85.76 RHINORRHOEA | 5 0.05 85.81 RHINOVIRUS INFECTION | 2 0.02 85.83 RHONCHI | 1 0.01 85.84 RIB FRACTURE | 3 0.03 85.87 RIGHT VENTRICULAR FAILURE | 1 0.01 85.88 ROAD TRAFFIC ACCIDENT | 10 0.10 85.98 ROTATOR CUFF REPAIR | 1 0.01 85.99 ROTATOR CUFF SYNDROME | 3 0.03 86.02 SALIVA ALTERED | 1 0.01 86.03 SALIVARY GLAND DISORDER | 1 0.01 86.04 SALIVARY HYPERSECRETION | 7 0.07 86.11 SCAB | 1 0.01 86.12 SCAN ABDOMEN ABNORMAL | 1 0.01 86.13 SCAR | 1 0.01 86.14 SCEDOSPORIUM INFECTION | 1 0.01 86.15 SCIATICA | 2 0.02 86.17 SCLERAL HAEMORRHAGE | 1 0.01 86.18 SCLERODERMA | 1 0.01 86.19 SCLEROSING ENCAPSULATING PERITONITIS | 1 0.01 86.20 SCOLIOSIS | 2 0.02 86.22 SCOTOMA | 3 0.03 86.25 SCRATCH | 1 0.01 86.26 SCREAMING | 2 0.02 86.28 SCROTAL DISORDER | 1 0.01 86.29 SCROTAL SWELLING | 1 0.01 86.30 SCROTAL ULCER | 1 0.01 86.31 SEASONAL ALLERGY | 1 0.01 86.32 SECONDARY SEQUESTRUM | 1 0.01 86.33 SELF INJURIOUS BEHAVIOUR | 4 0.04 86.37 SELF MUTILATION | 1 0.01 86.38 SELF-INJURIOUS IDEATION | 1 0.01 86.39 SENSE OF OPPRESSION | 1 0.01 86.40 SENSITIVITY OF TEETH | 1 0.01 86.41 SENSORY DISTURBANCE | 3 0.03 86.44 SENSORY LOSS | 1 0.01 86.45 SEPSIS | 34 0.34 86.79 SEPSIS NEONATAL | 1 0.01 86.80 SEPTIC ARTHRITIS STAPHYLOCOCCAL | 1 0.01 86.81 SEPTIC SHOCK | 9 0.09 86.90 SEQUESTRECTOMY | 1 0.01 86.91 SEROTONIN SYNDROME | 3 0.03 86.94 SERRATIA INFECTION | 2 0.02 86.96 SERUM FERRITIN INCREASED | 3 0.03 86.99 SEXUAL DYSFUNCTION | 1 0.01 87.00 SHOCK | 12 0.12 87.12 SHOCK HAEMORRHAGIC | 1 0.01 87.13 SICK SINUS SYNDROME | 2 0.02 87.15 SICKLE CELL ANAEMIA | 1 0.01 87.16 SICKLE CELL ANAEMIA WITH CRISIS | 2 0.02 87.18 SIDEROBLASTIC ANAEMIA | 1 0.01 87.19 SIGMOIDITIS | 1 0.01 87.20 SILENT MYOCARDIAL INFARCTION | 1 0.01 87.21 SIMILAR REACTION ON PREVIOUS EXPOSURE.. | 1 0.01 87.22 SINGLE FUNCTIONAL KIDNEY | 1 0.01 87.23 SINUS ARREST | 2 0.02 87.25 SINUS BRADYCARDIA | 6 0.06 87.31 SINUS DISORDER | 1 0.01 87.32 SINUS HEADACHE | 1 0.01 87.33 SINUS POLYP | 1 0.01 87.34 SINUS TACHYCARDIA | 4 0.04 87.38 SINUSITIS | 6 0.06 87.44 SJOGREN'S SYNDROME | 2 0.02 87.46 SKELETAL INJURY | 2 0.02 87.48 SKIN ATROPHY | 1 0.01 87.49 SKIN BURNING SENSATION | 4 0.04 87.53 SKIN CANCER | 1 0.01 87.54 SKIN DISCOLOURATION | 5 0.05 87.59 SKIN DISORDER | 2 0.02 87.61 SKIN EROSION | 1 0.01 87.62 SKIN EXFOLIATION | 8 0.08 87.70 SKIN LACERATION | 4 0.04 87.74 SKIN LESION | 3 0.03 87.77 SKIN NECROSIS | 1 0.01 87.78 SKIN ODOUR ABNORMAL | 1 0.01 87.79 SKIN REACTION | 4 0.04 87.83 SKIN TEST POSITIVE | 1 0.01 87.84 SKIN TOXICITY | 1 0.01 87.85 SKIN ULCER | 8 0.08 87.93 SKULL FRACTURE | 1 0.01 87.94 SLEEP APNOEA SYNDROME | 4 0.04 87.98 SLEEP DISORDER | 8 0.08 88.06 SLEEP TERROR | 1 0.01 88.07 SMALL INTESTINAL OBSTRUCTION | 4 0.04 88.11 SMEAR CERVIX ABNORMAL | 1 0.01 88.12 SNEEZING | 3 0.03 88.15 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 88.16 SOFT TISSUE INFECTION | 2 0.02 88.18 SOFT TISSUE NECROSIS | 2 0.02 88.20 SOLILOQUY | 1 0.01 88.21 SOMNAMBULISM | 2 0.02 88.23 SOMNOLENCE | 48 0.48 88.71 SPEECH DISORDER | 15 0.15 88.86 SPEECH DISORDER DEVELOPMENTAL | 2 0.02 88.88 SPINAL COLUMN STENOSIS | 3 0.03 88.91 SPINAL COMPRESSION FRACTURE | 3 0.03 88.94 SPINAL CORD INJURY | 1 0.01 88.95 SPINAL DISORDER | 2 0.02 88.97 SPINAL FRACTURE | 8 0.08 89.05 SPINAL FUSION SURGERY | 1 0.01 89.06 SPINAL OPERATION | 1 0.01 89.07 SPINAL OSTEOARTHRITIS | 1 0.01 89.08 SPLENIC INFARCTION | 1 0.01 89.09 SPLENIC NEOPLASM MALIGNANCY UNSPECIFIED | 1 0.01 89.10 SPLENIC VEIN THROMBOSIS | 1 0.01 89.11 SPLENOMEGALY | 4 0.04 89.15 SPONDYLOLISTHESIS | 2 0.02 89.17 SPONTANEOUS PENILE ERECTION | 1 0.01 89.18 SPUTUM DISCOLOURED | 1 0.01 89.19 SPUTUM RETENTION | 1 0.01 89.20 SQUAMOUS CELL CARCINOMA | 5 0.05 89.25 SQUAMOUS CELL CARCINOMA OF SKIN | 6 0.06 89.31 STAPHYLOCOCCAL ABSCESS | 1 0.01 89.32 STAPHYLOCOCCAL INFECTION | 12 0.12 89.44 STAPHYLOCOCCAL SEPSIS | 2 0.02 89.46 STASIS DERMATITIS | 1 0.01 89.47 STATUS EPILEPTICUS | 5 0.05 89.52 STENOTROPHOMONAS INFECTION | 1 0.01 89.53 STENT PLACEMENT | 4 0.04 89.57 STEVENS-JOHNSON SYNDROME | 10 0.10 89.67 STILLBIRTH | 1 0.01 89.68 STOMACH DISCOMFORT | 4 0.04 89.72 STOMATITIS | 8 0.08 89.80 STREPTOCOCCAL INFECTION | 4 0.04 89.84 STRESS | 6 0.06 89.90 STRESS FRACTURE | 2 0.02 89.92 STUPOR | 4 0.04 89.96 SUBARACHNOID HAEMORRHAGE | 4 0.04 90.00 SUBCLAVIAN VEIN THROMBOSIS | 1 0.01 90.01 SUBCORNEAL PUSTULAR DERMATOSIS | 1 0.01 90.02 SUBCUTANEOUS ABSCESS | 1 0.01 90.03 SUBCUTANEOUS NODULE | 2 0.02 90.05 SUBDURAL HAEMATOMA | 1 0.01 90.06 SUDDEN DEATH | 7 0.07 90.13 SUDDEN ONSET OF SLEEP | 1 0.01 90.14 SUFFOCATION FEELING | 1 0.01 90.15 SUICIDAL IDEATION | 14 0.14 90.29 SUICIDE ATTEMPT | 14 0.14 90.43 SUPERIOR SAGITTAL SINUS THROMBOSIS | 1 0.01 90.44 SUPRAVENTRICULAR EXTRASYSTOLES | 2 0.02 90.46 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 90.49 SURGERY | 8 0.08 90.57 SURGICAL PROCEDURE REPEATED | 1 0.01 90.58 SWELLING | 10 0.10 90.68 SWELLING FACE | 9 0.09 90.77 SWOLLEN TONGUE | 14 0.14 90.91 SYMPATHETIC POSTERIOR CERVICAL SYNDROME | 1 0.01 90.92 SYNCOPE | 17 0.17 91.09 SYNOVIAL CYST | 2 0.02 91.11 SYSTEMIC CANDIDA | 1 0.01 91.12 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 1 0.01 91.13 SYSTEMIC LUPUS ERYTHEMATOSUS | 6 0.06 91.19 SYSTEMIC MYCOSIS | 1 0.01 91.20 SYSTEMIC SCLEROSIS | 1 0.01 91.21 T-CELL LYMPHOMA | 1 0.01 91.22 TACHYARRHYTHMIA | 1 0.01 91.23 TACHYCARDIA | 22 0.22 91.45 TACHYPNOEA | 5 0.05 91.50 TAKAYASU'S ARTERITIS | 1 0.01 91.51 TARDIVE DYSKINESIA | 3 0.03 91.54 TEMPERATURE INTOLERANCE | 1 0.01 91.55 TEMPERATURE REGULATION DISORDER | 1 0.01 91.56 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 91.57 TENDON DISORDER | 1 0.01 91.58 TENDON INJURY | 1 0.01 91.59 TENDON RUPTURE | 2 0.02 91.61 TENDONITIS | 2 0.02 91.63 TENSION | 1 0.01 91.64 TENSION HEADACHE | 1 0.01 91.65 TERATOGENICITY | 1 0.01 91.66 TESTICULAR PAIN | 2 0.02 91.68 TETANY | 1 0.01 91.69 THERAPEUTIC AGENT TOXICITY | 3 0.03 91.72 THERAPEUTIC PROCEDURE | 1 0.01 91.73 THERAPEUTIC PRODUCT CONTAMINATION | 1 0.01 91.74 THERAPEUTIC RESPONSE DECREASED | 7 0.07 91.81 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 3 0.03 91.84 THERMAL BURN | 2 0.02 91.86 THINKING ABNORMAL | 1 0.01 91.87 THIRST | 5 0.05 91.92 THREATENED LABOUR | 1 0.01 91.93 THROAT IRRITATION | 2 0.02 91.95 THROAT TIGHTNESS | 3 0.03 91.98 THROMBOCYTHAEMIA | 1 0.01 91.99 THROMBOCYTOPENIA | 34 0.34 92.33 THROMBOPHLEBITIS | 1 0.01 92.34 THROMBOPHLEBITIS SEPTIC | 1 0.01 92.35 THROMBOPHLEBITIS SUPERFICIAL | 2 0.02 92.37 THROMBOSIS | 9 0.09 92.46 THROMBOSIS IN DEVICE | 4 0.04 92.50 THROMBOSIS MESENTERIC VESSEL | 1 0.01 92.51 THROMBOTIC MICROANGIOPATHY | 1 0.01 92.52 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 92.53 THYROID DISORDER | 1 0.01 92.54 THYROID GLAND SCAN ABNORMAL | 1 0.01 92.55 THYROID NEOPLASM | 1 0.01 92.56 THYROID OPERATION | 1 0.01 92.57 THYROIDITIS | 1 0.01 92.58 TIC | 2 0.02 92.60 TINEA INFECTION | 1 0.01 92.61 TINEA PEDIS | 1 0.01 92.62 TINNITUS | 9 0.09 92.71 TOE AMPUTATION | 4 0.04 92.75 TONGUE BLACK HAIRY | 1 0.01 92.76 TONGUE DISORDER | 2 0.02 92.78 TONGUE ERUPTION | 1 0.01 92.79 TONGUE EXFOLIATION | 1 0.01 92.80 TONGUE HAEMATOMA | 2 0.02 92.82 TONGUE HAEMORRHAGE | 3 0.03 92.85 TONGUE PARALYSIS | 1 0.01 92.86 TONGUE ULCERATION | 2 0.02 92.88 TONIC CONVULSION | 1 0.01 92.89 TONSILLAR INFLAMMATION | 1 0.01 92.90 TONSILLECTOMY | 1 0.01 92.91 TONSILLITIS | 1 0.01 92.92 TOOTH ABSCESS | 2 0.02 92.94 TOOTH DISORDER | 4 0.04 92.98 TOOTH EXTRACTION | 12 0.12 93.10 TOOTH FRACTURE | 1 0.01 93.11 TOOTH INFECTION | 4 0.04 93.15 TOOTH LOSS | 9 0.09 93.24 TOOTHACHE | 4 0.04 93.28 TORSADE DE POINTES | 2 0.02 93.30 TORTICOLLIS | 1 0.01 93.31 TOXIC ENCEPHALOPATHY | 2 0.02 93.33 TOXIC EPIDERMAL NECROLYSIS | 4 0.04 93.37 TOXIC SKIN ERUPTION | 8 0.08 93.45 TRACHEAL FISTULA | 1 0.01 93.46 TRACHEAL OBSTRUCTION | 1 0.01 93.47 TRACHEO-OESOPHAGEAL FISTULA | 1 0.01 93.48 TRACHEOMALACIA | 1 0.01 93.49 TRACHEOSTOMY | 1 0.01 93.50 TRANSAMINASES INCREASED | 12 0.12 93.62 TRANSFERRIN SATURATION DECREASED | 1 0.01 93.63 TRANSIENT ISCHAEMIC ATTACK | 12 0.12 93.75 TRANSITIONAL CELL CARCINOMA | 1 0.01 93.76 TRANSPLANT | 1 0.01 93.77 TRANSPLANT FAILURE | 1 0.01 93.78 TRANSPLANT REJECTION | 1 0.01 93.79 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 93.80 TRAUMATIC HAEMATOMA | 1 0.01 93.81 TREATMENT FAILURE | 1 0.01 93.82 TREATMENT NONCOMPLIANCE | 9 0.09 93.91 TREMOR | 32 0.32 94.23 TREMOR NEONATAL | 1 0.01 94.24 TRICUSPID VALVE PROLAPSE | 1 0.01 94.25 TRISOMY 21 | 1 0.01 94.26 TROPONIN INCREASED | 3 0.03 94.29 TUBERCULOSIS | 4 0.04 94.33 TUBERCULOSIS BLADDER | 1 0.01 94.34 TUBERCULOSIS SKIN TEST POSITIVE | 1 0.01 94.35 TUBERCULOUS PLEURISY | 1 0.01 94.36 TUBULOINTERSTITIAL NEPHRITIS | 1 0.01 94.37 TUMOUR EXCISION | 1 0.01 94.38 TUMOUR FLARE | 1 0.01 94.39 TUMOUR HAEMORRHAGE | 2 0.02 94.41 TUMOUR LYSIS SYNDROME | 3 0.03 94.44 TUMOUR PAIN | 1 0.01 94.45 TUNNEL VISION | 1 0.01 94.46 TYMPANIC MEMBRANE HYPERAEMIA | 1 0.01 94.47 TYPE 1 DIABETES MELLITUS | 2 0.02 94.49 TYPE 2 DIABETES MELLITUS | 11 0.11 94.60 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 94.61 ULCER | 2 0.02 94.63 ULCERATIVE KERATITIS | 1 0.01 94.64 ULNA FRACTURE | 1 0.01 94.65 ULTRASOUND ABDOMEN ABNORMAL | 1 0.01 94.66 ULTRASOUND DOPPLER | 1 0.01 94.67 ULTRASOUND SCAN ABNORMAL | 1 0.01 94.68 UMBILICAL CORD ABNORMALITY | 1 0.01 94.69 UNEVALUABLE EVENT | 8 0.08 94.77 UNINTENDED PREGNANCY | 4 0.04 94.81 UNIVENTRICULAR HEART | 1 0.01 94.82 UNRESPONSIVE TO STIMULI | 8 0.08 94.90 UPPER GASTROINTESTINAL HAEMORRHAGE | 4 0.04 94.94 UPPER LIMB FRACTURE | 3 0.03 94.97 UPPER RESPIRATORY TRACT INFECTION | 4 0.04 95.01 UPPER RESPIRATORY TRACT INFLAMMATION | 1 0.01 95.02 URETERIC OBSTRUCTION | 1 0.01 95.03 URETERIC STENOSIS | 1 0.01 95.04 URETEROCELE | 1 0.01 95.05 URGE INCONTINENCE | 10 0.10 95.15 URINARY BLADDER HAEMORRHAGE | 1 0.01 95.16 URINARY INCONTINENCE | 5 0.05 95.21 URINARY RETENTION | 16 0.16 95.37 URINARY TRACT DISORDER | 1 0.01 95.38 URINARY TRACT INFECTION | 24 0.24 95.62 URINARY TRACT INFECTION STAPHYLOCOCCAL | 1 0.01 95.63 URINARY TRACT OBSTRUCTION | 1 0.01 95.64 URINE AMINO ACID LEVEL INCREASED | 1 0.01 95.65 URINE AMYLASE INCREASED | 1 0.01 95.66 URINE COPPER INCREASED | 1 0.01 95.67 URINE KETONE BODY PRESENT | 1 0.01 95.68 URINE ODOUR ABNORMAL | 1 0.01 95.69 URINE OUTPUT DECREASED | 3 0.03 95.72 URINOMA | 1 0.01 95.73 UROGENITAL INFECTION BACTERIAL | 1 0.01 95.74 URTICARIA | 14 0.14 95.88 UTERINE CONTRACTIONS DURING PREGNANCY | 1 0.01 95.89 UTERINE DILATION AND CURETTAGE | 1 0.01 95.90 UTERINE DISORDER | 1 0.01 95.91 UTERINE LEIOMYOMA | 1 0.01 95.92 UTERINE OPERATION | 1 0.01 95.93 UTERINE POLYP | 1 0.01 95.94 VAGINAL ABSCESS | 1 0.01 95.95 VAGINAL CELLULITIS | 1 0.01 95.96 VAGINAL HAEMORRHAGE | 8 0.08 96.04 VARICELLA | 4 0.04 96.08 VARICOPHLEBITIS | 1 0.01 96.09 VARICOSE VEIN | 5 0.05 96.14 VASCULAR GRAFT | 2 0.02 96.16 VASCULAR PURPURA | 1 0.01 96.17 VASCULAR STENOSIS | 1 0.01 96.18 VASCULITIS | 6 0.06 96.24 VASODILATATION | 2 0.02 96.26 VEIN PAIN | 1 0.01 96.27 VENA CAVA FILTER INSERTION | 1 0.01 96.28 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.29 VENOUS OCCLUSION | 1 0.01 96.30 VENOUS THROMBOSIS | 2 0.02 96.32 VENTRICULAR DYSFUNCTION | 2 0.02 96.34 VENTRICULAR EXTRASYSTOLES | 6 0.06 96.40 VENTRICULAR FIBRILLATION | 5 0.05 96.45 VENTRICULAR HYPERTROPHY | 3 0.03 96.48 VENTRICULAR HYPOKINESIA | 2 0.02 96.50 VENTRICULAR HYPOPLASIA | 1 0.01 96.51 VENTRICULAR INTERNAL DIAMETER ABNORMAL | 1 0.01 96.52 VENTRICULAR SEPTAL DEFECT | 2 0.02 96.54 VENTRICULAR TACHYCARDIA | 3 0.03 96.57 VERBAL ABUSE | 1 0.01 96.58 VERTEBRAL INJURY | 1 0.01 96.59 VERTIGO | 8 0.08 96.67 VERTIGO POSITIONAL | 1 0.01 96.68 VESICOURETERIC REFLUX | 1 0.01 96.69 VESSEL PUNCTURE SITE HAEMATOMA | 1 0.01 96.70 VESTIBULAR DISORDER | 1 0.01 96.71 VICTIM OF HOMICIDE | 1 0.01 96.72 VIOLENCE-RELATED SYMPTOM | 1 0.01 96.73 VIRAL INFECTION | 10 0.10 96.83 VIRAL MUTATION IDENTIFIED | 1 0.01 96.84 VIRAL PERICARDITIS | 1 0.01 96.85 VIRAL UPPER RESPIRATORY TRACT INFECTION | 1 0.01 96.86 VIRUS URINE TEST POSITIVE | 1 0.01 96.87 VISION ABNORMAL NEONATAL | 1 0.01 96.88 VISION BLURRED | 14 0.14 97.02 VISUAL ACUITY REDUCED | 18 0.18 97.20 VISUAL DISTURBANCE | 17 0.17 97.37 VISUAL FIELD DEFECT | 4 0.04 97.41 VITAMIN B1 DEFICIENCY | 1 0.01 97.42 VITAMIN B12 DEFICIENCY | 2 0.02 97.44 VITH NERVE PARALYSIS | 1 0.01 97.45 VITREOUS DISORDER | 1 0.01 97.46 VITREOUS FLOATERS | 2 0.02 97.48 VITREOUS HAEMORRHAGE | 1 0.01 97.49 VOCAL CORD NEOPLASM | 2 0.02 97.51 VOLVULUS | 1 0.01 97.52 VOMITING | 89 0.89 98.41 VULVAL CANCER | 2 0.02 98.43 VULVAL DISORDER | 1 0.01 98.44 VULVAL HAEMORRHAGE | 1 0.01 98.45 VULVOVAGINAL MYCOTIC INFECTION | 1 0.01 98.46 WALDENSTROM'S MACROGLOBULINAEMIA | 2 0.02 98.48 WALKING DISABILITY | 1 0.01 98.49 WEIGHT DECREASE NEONATAL | 1 0.01 98.50 WEIGHT DECREASED | 45 0.45 98.95 WEIGHT FLUCTUATION | 1 0.01 98.96 WEIGHT INCREASED | 30 0.30 99.26 WEIGHT LOSS POOR | 2 0.02 99.28 WHEEZING | 6 0.06 99.34 WHITE BLOOD CELL COUNT DECREASED | 30 0.30 99.64 WHITE BLOOD CELL COUNT INCREASED | 15 0.15 99.79 WHITE BLOOD CELL DISORDER | 1 0.01 99.80 WITHDRAWAL BLEEDING IRREGULAR | 1 0.01 99.81 WOUND DEHISCENCE | 1 0.01 99.82 WOUND DRAINAGE | 1 0.01 99.83 WOUND HAEMORRHAGE | 1 0.01 99.84 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 99.85 WRIST FRACTURE | 1 0.01 99.86 WRONG DRUG ADMINISTERED | 1 0.01 99.87 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 4 0.04 99.91 X-RAY ABNORMAL | 2 0.02 99.93 YAWNING | 3 0.03 99.96 YELLOW SKIN | 3 0.03 99.99 ZYGOMYCOSIS | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015